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ABSTRACT

African trypanosomes are protozoan parasites that cause the diseases African
sleeping sickness and nagana, in humans and cattle respectively. These parasites have
complex life cycles with infection of a mammalian host, ~5mM glucose, following
transmission by an insect vector, essentially zero glucose. With these pathogens being
exposed to rapidly changing glucose abundance in a host-dependent manner, the ability to
sense and rapidly respond to changes in the availability of the hexose are critical. First, I
provide a review of glucose metabolism in Trypanosoma brucei. Then, we explore the role
of the catalytic α subunit of AMPK, a eukaryotic master regulator of energy, in procyclic
form T. brucei. We found that the larger species of AMPKα1, coined AMPKα1+, was more
abundant in the presence of glucose, and other metabolizable sugars. Subcellular location
of AMPKα1 was similar regardless of glucose abundance. Phosphorylated AMPKα1 had
an association with membranes, hypothesized to connect nutrient sensing and signaling
pathways. Lastly, we describe how pleomorphic parasites respond to glucose depletion
with a focus on parasite changes in energy metabolism and growth.

Long slender

bloodstream form parasites were rapidly killed as glucose concentrations fell, while short
stumpy bloodstream form parasites persisted to differentiate into the insect stage procyclic
form parasite. Both differentiation and growth of resulting procyclic form parasites were
inhibited by glucose and non-metabolizable glucose analogs and these parasites were found
to have upregulated amino acid metabolic pathway component gene expression.

In

summary, glucose transitions from the primary metabolite of the blood stage infection to a

ii

negative regulator of cell development and growth in the insect vector. These data suggest
that glucose is not only a key metabolic agent but is also an important signaling molecule
and may be signaling through TbAMPK.
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CHAPTER ONE
LITERATURE REVIEW
GLUCOSE METABOLISM AND REGULATION IN AFRICAN TRYPANOSOMES

Introduction
Trypanosoma brucei
Kinetoplastids are a group of flagellated protozoa which include the species
Trypanosoma and Leishmania. Kinetoplastids can cause disease in humans and
economically important animal species, causing a substantial economic burden in impacted
areas. The parasites in this group that cause human disease include Trypanosoma cruzi, T.
brucei, and Leishmania spp and cause Chagas disease, African sleeping sickness, and
leishmaniasis, respectively. These parasites have complex life cycles with infection of a
mammalian host following transmission by an insect vector (Figure 1.1) (1).

1
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T. brucei is a unicellular protozoan parasite that is transmitted by the tsetse fly. Nonproliferative metacyclic trypomastigotes are injected from the salivary gland of the fly into
the mammalian host during a blood meal (2). These parasites receive a variety of
environmental cues, including temperature, nutrient availability, and host immune
response, which induce differentiation into the long slender form (LS). LS parasites are
proliferative and establish an infection in the bloodstream. Interestingly, the T. brucei life
cycle is completely extracellular, compared to T. cruzi and Leishmania spp. Eventually,
LS parasites overcome the blood-brain barrier and establish infection in the brain. LS
parasites differentiate into short stumpy forms (SS) in a density dependent fashion in the
mammalian bloodstream (3). Upon receiving molecular cues from neighboring parasites,
LS alter their surface membrane proteins (4,5), remodel metabolism (6,7), and become
non-dividing SS. This differentiation is cued by a small molecule termed the stumpyinducing factor, SIF (8). Rojas et al have shown that oligopeptides are partially responsible
for the composition of SIF (9). Parasite secreted proteases to degrade host proteins, which
are then perceived by the parasites by an orphan G-protein-coupled receptor, TbGPR89,
and trigger SS formation (10).
When a tsetse fly takes a bloodmeal from an infected mammal LS and SS parasites are
ingested. Evidence suggests that SS are preadapted to the fly midgut environment, having
a unique surface molecule composition and altered metabolism that seems to be appropriate
for life in the fly (11). Our understanding of SS differentiation into procyclic forms (PF) is
more extensive, due to the historical belief that SS were key intermediates in the process
(12). SS parasites are cued to become PF by changes in nutrient availability, temperature
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change, and low pH and protease activity and differentiate into PF (13,14). Coincident with
differentiation, amino acids become important metabolites for the PF parasites. In the fly
hemolymph parasites consume primarily proline, through oxidative phosphorylation, to
generate ATP. Parasites migrate from the midgut into the salivary glands of the fly where
they differentiate into epimastigotes and establish infection. Proliferative epimastigotes
differentiate into quiescent metacyclic trypomastigotes in the salivary gland, a mechanism
that is not well understood. When this infected fly takes a bloodmeal it injects metacyclic
parasites into the mammalian bloodstream, completing the parasites life cycle (2).
Nutrient availability in the various host environments is different. Glucose, for
example, can have marked availability differences between host and vector. Additionally,
the abundance of glucose can vary in the different tissues of the mammal and insect. For
example, glucose is abundant in the mammalian bloodstream and in organs like the brain,
being maintained at millimolar levels by the host (15). Concentrations in other tissues is
likely considerably lower, with adipose glucose half as abundant as blood glucose (16).
Additionally, glucose levels in the insect vectors can differ from those in the mammal.
Trypanosomes taken up in a bloodmeal by the tsetse fly experience a precipitous loss of
glucose in the environment, with the blood sugar falling from ~5mM to nearly undetectable
within 15 minutes of the fly feeding (17).
With these pathogens being exposed to rapidly changing glucose abundance in a
host-dependent manner, the ability to sense and rapidly respond to changes in the
availability of glucose are critical. Responses to changes in glucose availability include
alteration of metabolic strategies, requiring the regulation of different pathways to meet the
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needs of the cell. In this review, mechanisms used by yeast and mammalian cells to
perceive and respond to changes in glucose availability, and their connection to AMPK
signaling, will be considered and then similarities and differences in T. brucei will be
discussed.

Glucose metabolism
Glucose serves as a critical nutrient for most organisms. Glucose enters cells through
either active or passive mechanisms. Once glucose enters the cell it is catalyzed to glucose6-phosphate (G6P) by an enzyme of the hexokinase, or glucokinase, family. The fate of
G6P is varied and depends on the metabolic needs of the cell- which is dependent on the
environment in which the cell resides. Eukaryotic glucose metabolism is summarized in
Figure 1.2. Under conditions of metabolic demand (low ATP) G6P enters glycolysis. The
metabolism of this sugar through glycolysis yields two NADH reducing equivalents, two
ATP, and two pyruvate molecules per molecule of glucose. The pyruvate may be further
metabolized by oxidation in the citric acid (TCA) cycle, and subsequently the electron
transport chain (ETC), to generate additional ATP. The combination of these two metabolic
pathways, TCA cycle and ETC, is known as oxidative phosphorylation. Glucose uptake
may be upregulated under conditions of nutrient depletion to increase the influx of glucose
to meet cellular demands. Conversely, other metabolites can be used to generate ATP.
Glucose is also metabolized for use in the pentose-phosphate pathway, which generates
reducing equivalents and nucleotide biosynthetic intermediates. G6P enters the pentose
phosphate pathway to generate NADPH and pentose sugars. This process happens in
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parallel with glycolysis and is primarily regulated through the abundance of reducing
equivalents in the cell.
Glucose abundance may be low in some environments, so eukaryotes employ other
mechanisms to generate glucose for essential cellular processes. In some organisms
glycogen, a polymer of glucose, is stored in some cells and can be broken down during
periods of glucose starvation in a process called glycogenolysis. Gluconeogenesis is the
process which eukaryotes reverse much of glycolysis to shuttle G6P into other essential
pathways when glucose abundance is low in the environment.

6

Figure 1.2: Schematic of eukaryotic carbohydrate metabolism (Taken from BioVision
website). Glucose is central in several metabolic pathways. Glucose is broken down into
pyruvate through glycolysis to generate ATP. Pyruvate is converted into acetyl-CoA and
is metabolized through the citric acid (TCA) cycle , and subsequently the electron transport
chain (ETC) to generate ATP. Pyruvate can also be converted into lactate for excretion.
Glucose can also be utilized in the pentose-phosphate pathway to generate other molecules.
Some amino acids can be shuttled into various metabolic pathways to generate ATP. Fatty
acids can be degraded into acetyl-CoA to go through the TCA cycle and ETC to generate
ATP. Pyruvate can be metabolized into glucose through gluconeogenesis. Glucose can be
polymerized into glycogen molecules for cellular storage through glycogenesis. Glycogen
can be degraded into glucose monomers through glycogenolysis.
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Yeast
Glucose metabolism
Yeast use concentration-dependent facilitated diffusion to acquire stereospecific
hexoses (18). This uptake occurs through a broad family of transporters that includes both
high and low affinity hexoses transports with members of the Hxt family (19,20) (Figure
1.3, Hxt). These hexose transporters vary in binding affinity for glucose, fructose, and
mannose, and are differentially expressed based on the extracellular environment of the
yeast. Low affinity hexose transport occurs through facilitated diffusion. These transporters
are constitutively expressed throughout the yeast life cycle (21). Cells begin to express the
high affinity hexose transporters as hexoses become depleted from the environment. High
affinity hexose transport is inhibited by the presence of hexose in the environment, through
general repression control. This transport is reliant on the activity of glucokinase, which
phosphorylates free glucose to yield G6P, functionally reducing the intracellular pool of
free glucose (19).
High affinity glucose transporters include SNF3, HXT1, and HXT2. SNF3 has
been shown to play a role in glucose repression, although it is not required for regulation
(22). Intracellular glucose levels are sensed by some hexose transporters as glucose crosses
the plasma membrane (23) (Figure 1.3, Hxt, Rgt2/Snf3, Gpr1). These hexose transporters
serve as signaling proteins which increases metabolic efficiency and are common among
eukaryotes. The variation of hexose transporters allows the cells to express the appropriate
transporter for the environmental sugar concentration. The regulation of hexose transporter
abundance on the plasma membrane is regulated at the both the transcriptional and
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translational levels through Rgt1, central to all three glucose signaling pathways in yeast
(24) (Figure 1.3, Rgt1).

Figure 1.3: Glucose signaling pathways in yeast. The hexose transporters, Hxt, transport
glucose into the cytoplasm and signal through Snf1, which is influenced by hexokinase
activity, Hxk2 (Snf1-Mig1 pathway -left). Depending on extracellular glucose
concentration either Rgt2 or Snf3 transduces the signal to the cytoplasm and signals for
glucose-based gene repression (Rgt2/Snf3 pathway - middle). The cAMP-PKA pathway
(right) responds to extracellular glucose concentrations and transduces the intracellular
signal through the increase in cytoplasmic cyclic AMP (cAMP) and activates the glucose
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repressed gene expression. Reprinted with permission from Elsevier Science &
Technology Journals, General Subjects. Copyright: Elsevier Science & Technology
Journals, 2013 (25).

Snf3 and Rgt2 proteins are transmembrane proteins that bind glucose, but do not
transport it (Figure 1.3, middle pathway). Snf3 and Rgt2 have cytoplasmic C-terminal tails
that are responsible for intracellular signal transduction from extracellular glucose
concentrations (26). These C-terminal tails recruit a signaling complex which is
responsible for transducing the signal of glucose abundance and controlling the gene
expression of HXTs (23).
Yeast regulates gene expression based on available carbon source (27).
Transcription initiation and activation can be regulated in response to glucose abundance
through multi-protein complexes that interact with DNA promoter regions. Nuclear
localization of Hxk2 (Figure 1.3, left pathway) has been shown to repress gene expression
in the presence of glucose. This occurs when Hxk2 binds the promoter, not allowing the
transcription initiation complex to form (23). Transcriptional regulation may also involve
small molecules or cofactors, whose concentration may affect the protein complexes
associated with gene promoters, altering the activity of those complexes. This commonly
occurs through allosteric regulation by intermediate metabolites. For example, fructose2,6-bisphosphate has an inhibitory effect on FBPase through a substrate negative feedback
mechanism (28).
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Yeast control translation based on nutrients and environmental stresses by means
of protein degradation, modification, and translocation (29). In response to high glucose
abundance yeast utilize glycolysis to generate ATP. As ATP is metabolized and ADP
accumulate this signals to protein kinase A (PKA) (Figure 1.3, PKA), target of rapamycin
complex 1 (TORC1), and Snf1 which initiates the alteration of transcription (30). PKA and
TORC1 have been found to play a role in regulating ribosome biogenesis and protein
synthesis, as well as gene expression of the hexose transporters, which is important because
these pathways are regulated by cellular cAMP levels (31) (Figure 1.3, right pathway).

SNF1 - AMPK homologue
The signaling molecule Snf1 also transduces signals, through its kinase activity,
based on glucose concentrations, by means of gene regulation (26) (Figure 1.3, Snf1- left
pathway). When environmental glucose is low, SNF1 acts to derepress glucose-repressible
genes. SNF1 is not transcriptionally regulated, but rather modified at the protein level (32).
SNF1 is a heterotrimeric serine/threonine protein kinase containing the catalytic α subunit
(Snf1), the scaffold β subunit (Gal83/Sip1/Sip2), and the regulatory γ subunit (Snf4). SNF1
is a master regulator of yeast environmental response, including nutrient abundance (33).
Activation of SNF1 involves phosphorylation of Threonine 210 of the catalytic α subunit,
this phosphorylation is a hallmark of SNF1 activation (34). The largest contributor to SNF1
activity is AMP:ATP ratios. When the intracellular AMP:ATP ratio is high, then SNF1
transduces signals to induce catabolic activities while suppressing anabolic activities (35).
Regulation of SNF1 occurs through post-translational modifications (PTM) by upstream
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phosphatases and kinases, and various allosteric mechanisms (36). SNF1 directly plays a
role in glucose uptake and metabolism (25).

Figure 1.4: AMPK complex in Yeast. Schematic of the heterotrimeric AMP-Kinase
complex. Snf1 (blue) - the catalytic subunit, contains the active site for kinase activity and
complex activation occurs through phosphorylation on Threonine 210. Snf4 (purple) - the
scaffold subunit, contains autoinhibitory domain (AID) of Snf1. Gal83 (green) - the
regulatory subunit contains the binding domains for adenosine nucleotides (AXP) for
intracellular energy sensing.
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Mammals
Glucose metabolism
Mammalian cells use two mechanisms for glucose uptake, facilitated diffusion and
sodium-glucose co-transport (37). Na+-glucose symport is found in a limited number of
mammalian cell types whereas facilitated diffusion occurs in a plethora of cell types and
tissues. Facilitated diffusion of glucose is carried out through the GLUT family of proteins
(Figure 1.5, GLUT). Like the yeast Hxts, the GLUT proteins vary in their affinity for
glucose and are differentially expressed in response to environmental stimuli, being most
abundant in particular tissue types. For example, GLUT2 is the primary transporter of the
liver, where GLUT4 is found in adipose and muscle tissues. GLUT1 is common to many
tissues, and is the low affinity glucose transporter, where GLUT4 has high affinity for
glucose transport. (38).
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Figure 1.5: Overview of regulation of glucose metabolism through signaling
pathways. Schematic of glucose metabolism and nutrient metabolism in mammals.
Regulation occurs through nutrient abundance (glucose, glutamine, or leucine), or cellular
energy abundance (

AMP
ATP

). Lipogenesis and cholesterol synthesis are inhibited when

cellular energy is low, but activated in the presence of SREBP. Reprinted with permission
from Elsevier, Trends in Biotechnology. Copyright: Elsevier, 2016 (39).
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Mammalian multi-cellularity increases the complexity of glucose perception and
response pathways. The most studied example of glucose gene regulation in mammals is
the insulin-based pathway (Figure 1.5, through a receptor tyrosine kinase). Complex
carbohydrates from the diet are digested to yield glucose monomers that are used for
cellular metabolism. In response to increasing glucose levels from the meal, the pancreas
secretes the hormone insulin into the bloodstream, while simultaneously inhibiting
glucagon secretion. Insulin, promotes glucose uptake in other tissues (40). Generally, by
triggering an increase in GLUT gene expression and protein translocation to the plasma
membrane. Insulin induces expression of both GLUT1 & 4 to increase overall glucose
transport. Steroids decrease overall GLUT family expression, and in turn decrease
intracellular glucose, and lead to cellular degradation of glycogen (38).
The first reaction of glycolysis (Figure 1.5, glycolysis), glucose into glucose-6phosphate (G6P), is catalyzed by a hexokinase, which is distinct from the yeast
glucokinase. Mammalian cells have four types of hexokinases, with type IV being
glucokinase. Glucokinase differs from the three other types of hexokinases by having a
lower affinity (~ 6mM) and higher specificity for glucose, as well as lacking the traditional
negative allosteric feedback of G6P (41,42). Glucokinase plays a role in glucose response
through tissue specific expression, through a mechanism distinct from GLUT expression
(43). Glucokinase is repressed in hepatocytes during glucose depletion, whereas in the
pancreatic β-islet cells glucokinase expression remains unchanged (44). β-islet cells
respond to the metabolism of glucose into glucose-6-phosphate through glucokinase,
utilizing glucokinase activity as a metabolic sensor (45–47). The glucose concentration for
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optimal glucokinase activity mirrors blood glucose levels under normal conditions.
Hypoglycemia leads to inactivation of glucokinase, which is perceived by the β-islet cells
and leads to glucagon secretion. The downstream metabolic intermediates, from either
glycolysis or the pentose phosphate pathway, trigger differential gene expression through
transcription factors (48,49) (Figure 1.5).

AMPK
Nutrients, hormones, and other stimulants can influence proteins through posttranslational modifications or allosteric mechanisms. These include proteins within
signaling pathways and transcription factors (50). The master regulator AMP kinase
(AMPK), a homolog of yeast SNF1, is a heterotrimeric complex (Figure 1.6) and is
activated in response to high AMP/ADP:ATP levels, sensing low intracellular energy, and
signaling catabolic pathways. Inversely, mTORC1 is activated in the presence of insulin,
and signals anabolic pathways (39) (Figure 1.5, mTORC1).
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Figure 1.6: AMPK complex in Mammals. Schematic of the heterotrimeric AMP-Kinase
complex. AMPKα (blue) - the catalytic subunit, contains the active site for kinase activity
and complex activation occurs through phosphorylation on Threonine 172. AMPKβ
(purple) - the scaffold subunit, contains autoinhibitory domain (AID) of AMPKα. AMPKγ
(green) - the regulatory subunit contains the binding domains for adenosine nucleotides
(AXP) for intracellular energy sensing.

The enzymatically active AMPK is comprised of three unique subunits. The
catalytic α subunit, the scaffold β subunit, and the regulatory γ subunit (Figure 1.6). The
mammalian genome encodes two α isoforms, three β subunit isoforms, and two γ subunit
isoforms, for a possible combination of 12 distinct AMPK complexes (51). Regulation of
AMPK can occur through any one of the three subunits (51). Phosphorylation of the
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catalytic α subunit on threonine 172 leads to kinase activation. The scaffold β subunit can
be myristoylated, altering the subcellular location of the AMPK complex through
interactions with membranes (52). The regulatory γ subunit is responsible for sensing the
adenine nucleotides, and in turn allowing the activation of the catalytic α subunit (51).
These modifications of AMPK that alter activity occur in the cell by an increase in
AMP:ATP ratios, presence of cAMP or its analogs, or change of subunit isoforms (53,54).
Canonical activation of AMPK occurs through the increase in AMP:ATP ratio, triggering
the phosphorylation of Thr172 on the α subunit, which can occur through depletion of
environmental glucose. The resulting active complex phosphorylates a multitude of
proteins, activating some while simultaneously repressing others. AMPK activation has
been shown to act as a sensor for glucose, as well as association with some organellar
membranes (55).
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African Trypanosomes
Glucose metabolism
Trypanosoma brucei infects the bloodstream of mammals and the digestive tract of
the tsetse fly, living as an extracellular parasite during its entire life cycle. The glucose
concentration of mammalian blood is ~5 mM and is relatively constant (56). In the blood,
the parasite utilizes low affinity glucose transporters (trypanosome hexose transporter type
1s, THT1s) to acquire glucose through facilitated diffusion from the host environment (57–
59). Glucose moves from the cytoplasm to the glycosome through an unknown mechanism,
where a hexokinase phosphorylates it into glucose-6-phosphate (G6P), reducing the
concentration of glucose in the cell and enabling continued sugar uptake. Glycosomes are
parasite-specific specialized peroxisomes that compartmentalize most of glycolysis, along
with components of other metabolic pathways. These organelles have an unknown glucose
transport mechanism (60,61).
The differentiation from proliferative LS parasites into quiescent SS parasites
occurs in a density dependent fashion in the mammalian bloodstream (3) (Figure 1.7,
slender to stumpy in the bloodstream). As parasitemia increases in the mammalian
bloodstream, so does the concentration of the ‘stumpy inducing factor’ (SIF). LS parasites
sense environmental SIF, arrest their growth, and differentiate into SS forms (62). SS
parasites are characterized by quiescence, having a shortened morphology, with molecular
markers that include the upregulation of mitochondrial transcripts coincident with
mitochondrial expansion (Figure 1.7, Stumpy associated hallmarks). Additionally, the SS
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cells are resistant to mild acids and have proteins associated with differentiation (PAD) on
the cell surface (63,64). This quorum-sensing mechanism of parasite development has been
recently reviewed (in 3). It has been hypothesized that this stepwise transition in the
parasite lifecycle is necessary for colonization in the tsetse fly midgut and successful
transition into PF parasites (12). However, recent studies have shown that LS parasites can
differentiate directly into PF forms without the need for the SS lifecycle stage (66) and LS
have been shown to establish viable infections in tsetse flies without the SS intermediates
(67).
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Figure 1.7: Differentiation between Slender to Stumpy to Procyclic form T. brucei.
Slender form parasites reside in the mammalian bloodstream and have the associated
hallmarks. Stumpy forms are also present in the bloodstream but are morphologically and
metabolically distinct. Procyclic form parasites are generated in the tsetse fly midgut after
a bloodmeal and have the associated hallmarks. While progressing through the tsetse fly
parasites differentiation into epimastigotes forms then subsequently metacyclic forms to
be injected into a mammalian bloodstream during a tsetse bloodmeal and become slender
forms, completing their lifecycle. Reprinted with permission from The Company of
Biologists, Journal of cell science. Copyright: The Company of Biologists, 2005 (68).
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When a tsetse fly takes a bloodmeal from an infected mammal, both LS and SS T.
brucei parasites are ingested by the fly. Within 15 minutes the bloodmeal is digested in the
midgut and glucose levels become undetectable, an event that can trigger differentiation of
the short stumpy parasites into the insect stage procyclic form (PF) in vitro (17). The PF
parasites remodel their metabolism to overcome the absence of glucose and, in turn,
upregulate amino acid metabolism to consume primarily proline from the tsetse fly
hemolymph to generate ATP. Even though amino acids serve as the predominant carbon
source for the PFs, they express a high affinity glucose transporter, THT2, for uptake of
glucose that may be introduced into the fly midgut. THT2 transcripts are present in both
PF and BSF parasites, albeit at a significantly lower abundance in BSF parasites, whereas
THT1 transcripts are only present in BSF parasites (69,70). The mechanism of THT2
glucose uptake, facilitated diffusion, is similar to THT1 although the transporter has a much
higher affinity for glucose (71).
One of the canonical pathways for triggering SS to PF differentiation is citrate/cisaconitate treatment of SS forms (72). The TCA intermediate is taken up by the cells through
the PAD surface proteins and this triggers metabolic reprogramming and surface protein
alterations required for the PF stage (73). Other hallmarks of PF parasites include fully
functional mitochondria, kinetoplast repositing, and proliferation (63) (Figure 1.7,
procyclic associated hallmarks). During the transition from SS, parasites begin remodeling
their metabolism, to perform oxidative phosphorylation of amino acids while altering cell
surface proteins to successfully become PF (Figure 1.7, procyclic form in the tsetse midgut
with associated hall marks). The differentiation from SS parasites into PF parasites can
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occur in response to a number of stimuli, in addition to treatment with citrate/cis-aconitate
(74) (Figure 1.7, tsetse bloodmeal). One is the depletion of extracellular glucose, discussed
in Chapter Two (73).
Glycosomes are involved in T. brucei differentiation signaling. The development
from SS to PF is driven by protein phosphorylation-based signaling. Two proteins are key
to this response, TbPTP1 and TbPIP39 (14,75). TbPTP1 (protein tyrosine phosphatase 1)
is a negative regulator of PF development that inactivates TbPIP39 (TbPTP1-interacting
protein, 39kDa) to prevent the SS to PF transition. TbPIP39 transcript is abundant in SS
parasites, while protein levels increase in PF parasites. SS parasites receive signals in the
fly midgut and inactivate TbPTP1, which allows the phosphorylation, or activation, of
TbPIP39 and differentiation into PF parasites (63,75). Once phosphorylated, TbPIP39
relocates to glycosomes where it remains activated and unable to interact with TbPTP1
(75). This mechanism suggests a role for protein phosphorylation cascades coordinating
lifecycle-dependent changes in parasite metabolism.
Glucose enters the parasites through the THTs and it has been hypothesized that
these transports may be playing a secondary role in glucose sensing and signaling (71). PF
parasites utilize proline as their main metabolite, but preferentially metabolize glucose if
available. Under these conditions, when glucose becomes available, PF parasites rapidly
down-regulate proline transport and metabolism (76). Conversely, when PF parasites are
starved for glucose and have amino acids available to metabolize they up-regulate
tricarboxylic acid cycle transcripts (77).
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Previous work on trypanosomes discovered that glucose metabolism affects surface
molecule glycoprotein expression in PF parasites (78). Environmental glucose depletion,
or silencing of glycolytic enzymes, led to changes in expression of surface procyclins that
mirrored developmental responses in the fly that are coordinated with glucose reduction in
the bloodmeal fly midgut (78). Early PF parasites express GPEET procyclins but through
time they are replaced by EP procyclins (4). These data suggest a mechanism for
modulating PF surface molecule composition that is tied to glucose metabolism.

AMPK
All three AMP kinase subunits have been recently annotated in the trypanosome
genome. The catalytic AMPKα subunit has two annotated isoforms, 1 and 2
(Tb927.10.5310 and Tb927.3.4560, respectively) (79). The scaffold AMPKβ subunit has
one annotated gene (Tb927.8.2450), as well as the regulatory AMPKγ subunit
(Tb927.10.3700) (80). TbAMPKα isoform 1 and 2 are highly similar (Figure 1.8). Upon
further sequence analysis within the activation loop of the catalytic AMPKα subunit the
threonine associated with enzyme activation was conserved. The threonine is found at
position human AMPK (Thr183), yeast SNF1 (Thr210), TbAMPKα

(Thr165) and

TbAMPKα2 (Thr167) (Figure 1.8).
By immunoprecipitation of the TbAMPK complexes, Saldivia et al characterized
two unique AMPK complexes with distinct protein components (79). Combining the
immunoprecipitation data with proteins previously published to be associated with of
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TbAMPK (80), they concluded that T. brucei form two distinct AMPK complexes (Figure
1.9). TbAMPKα1 is associated with AMPKβ and AMPKγ subunits, as well as translation
factors and RNA binding proteins (Figure 1.9, top). Interestingly, when AMPKβ was used
for immunoprecipitation both isoforms of AMPKα were detected, along with hexokinase
1 (TbHK1) and other metabolic enzymes (Figure 1.9, bottom).
A comparison of AMPK homolog sequences, using human PRKAA1, human
PRKAA2, yeast SNF1, TbAMPKα1 and TbAMPKα2 (Table 1.1) revealed that yeast SNF1
had approximately 41% protein identity to each human AMPKα isoform, compared to
approximately 51% identity to either trypanosome AMPKα isoform. This modest level of
identity may reflect the unique mechanisms of activation and regulation between the three
different eukaryotes. The identity between the two human isoforms, PRKAA1 and
PRKAA2, was approximately 76%. Human AMPKα isoforms were approximately 47%
identical to each trypanosome AMPKα isoform. This discrepancy between human and
trypanosome sequences may be worth exploiting to discover novel therapeutics. The
identity between the two trypanosome isoforms was approximately 50%, which may reflect
different

roles

for

the

two

distinct

immunoprecipitation (Figure 1.9) (79).
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AMPK

complexes

discovered

during

SNF1
Protein
SNF1

PRKAA1

PRKAA2

TbAMPKα1

TbAMPKα2

41%

42%

51%

53%

76%

46%

48%

47%

48%

PRKAA1

41%

PRKAA2

42%

76%

TbAMPKα1

51%

46%

47%

50%

TbAMPKα2
53%
48%
48%
50%
Table 1.1: Percent identity of protein sequences between AMPKα homolgues. SNF1
uniprot P06782, PRKAA1 uniprot Q13131 (human AMPKα1), PRKAA2 uniprot P54646
(Human AMPKα2), TbAMPKα1 TriTryp Tb927.10.5310, TbAMPKα2 TriTryp
Tb927.3.4560. Protein sequence of subject (top row) was aligned to the protein sequence
of query (left column) using NCBI blastp suite-2sequences program.
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Figure 1.8: TbAMPKα isoform sequence analysis. Protein domain schematic of the two
trypanosome AMPKα isoforms (AIS: autoinhibitory site, β-SID: β-scaffold interacting
domain). Sequence alignment of the activation loop, highlighted in grey, within the kinase
domain of both trypanosome AMPKα isoforms against human AMPK and yeast SNF1.
Conserved threonine residue is highlighted in black. TbAMPKα1 Thr165, TbAMPKα2
Thr167, Hs-AMPK Thr183, SNF1 Thr210. Reprinted with permission from Elsevier
Science & Technology Journals, Cell reports. Copyright: Elsevier Science & Technology
Journals, (79).
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Figure 1.9: Two individual AMPK complexes interacting partners. Proteins found by
mass spectrometry analysis to be associated with either TbAMPKα1 (top) or TbAMPKβ
(bottom) through immunoprecipitation or previously published biochemical analysis.
Reprinted with permission from Elsevier Science & Technology Journals, Cell reports.
Copyright: Elsevier Science & Technology Journals, (79).
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Clemmens et al have shown that AMPK plays a role in regulating surface molecule
expression in T. brucei (80). One experiment performed was mass-spectrometry analysis
on procyclin isolates from PF parasites cultured in the presence of glucose, or PF parasites
with a knock-down of the AMPKβ subunit, or a knockdown of the AMPKγ subunit (Figure
1.10). PF parasites had several species of EP procyclin molecules detected after procyclin
isolation (Figure 1.10A). However, after the knockdown of either the AMPKβ or AMPKγ
subunit PF parasites were found to express GPEET procyclin much like the parasites
cultured in the absence of glucose (78) (Figure 1.10B). These experiments concluded that
the knockdown of two of the AMPK subunits (β or γ) caused an alteration in PF surface
molecule composition. The mass-spectrometry data from the AMPK subunit knockdowns
mirrored the profiles of PF parasites starved of glucose (78). Taken together, these data
suggest that AMPK may be playing a role regulating in surface molecule composition in
response to glucose metabolism.

29

Figure 1.10: PF surface molecule mass-spectrometry profile changes with the
knockdown of individual AMPK subunits A- Mass-spectrometry profile of procyclin
isolates of parental PF parasites (29-13) B- Mass-spectrometry profile of procyclin isolates
of PF parasites with AMPKβ knocked down (pZJMAMPKβ) C- Mass-spectrometry profile
of procyclin isolates of PF parasites with AMPKγ knocked down (pZJMAMPKγ).
Reprinted with permission from Elsevier Science & Technology Journals, Experimental
Parasitology. Copyright: Elsevier Science & Technology Journals, 2009 (80).
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AMPK responds to high AMP:ATP ratios, which may occur inside the parasites
during glucose starvation required for differentiation from SS into PF. How other
environmental signals play a role in T. brucei differentiation have been reviewed
(11,62,81). Low cellular ATP seems to be the common thread among several eukaryotic
differentiation signaling pathways (82). The AMP analog (8-pCT-2’-O-Me-5’-AMP) can
activate TbAMPK in LS parasites (79). Parasites treated with the analog upregulated
stumpy hallmark transcripts (Figure 1.11, PAD1 and PAD2) and PF specific transcript
(Figure 1.11, EP) while down-regulating LS associated transcripts (Figure 1.11, THT-1,
HpHbR, MYO (myosin), and VSG221). Treatment of TbAMPKα1 with the AMPK analog
led to an increase in phosphorylation of TbAMPKα1, suggesting activation of the subunit
(Figure 1.12) (79). This increase in TbAMPKα1 phosphorylation ( presumably activation)
was proposed to result in a signaling cascade that contributed to the remodeling of LS into
a SS transcript profile. Taken together, these data suggest a central role of TbAMPKα1 in
T. brucei differentiation. The role of TbAMPKα1 phosphorylation and glucose metabolism
will be explored in Chapter Three.
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Figure 1.11: Activation of TbAMPKα1 in LS parasites induces a stumpy-like
transcript profile. qRT-PCR analysis of transcripts from untreated LS parasites (grey)
compared to LS parasites treated with the AMP analog, 8-pCT-2’-O-Me-5’-AMP (blue).
MYO- myosin. * = p <0.05, ** = p <0.01, *** = p <0.005. Reprinted with permission from
Elsevier Science & Technology Journals, Cell reports. Copyright: Elsevier Science &
Technology Journals, (79).
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Figure 1.12: Activation of TbAMPKα1 in LS parasites with an AMP analog. Western
blot detecting both isoforms of phosphorylated TbAMPKα (TbAMPKα1 is 80.6 kDa and
TbAMPKα2 is 70.6kDa). Treatment with either cAMP or the AMP analog (8-pCT-2’-OMe-5’-AMP) only increases phosphorylation of TbAMPKα1, not TbAMPKα2. p-AMPK
detects both activated TbAMPKα isoforms. Control- loading control of cell equivalents.
VSG221- LS parasite specific surface molecule VSG protein abundance. Reprinted with
permission from Elsevier Science & Technology Journals, Cell reports. Copyright:
Elsevier Science & Technology Journals, (79).
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AMPK signaling is hypothesized to be at the center of coordination of parasite
differentiation, influencing metabolic changes in the mitochondria and glycosomes (83), a
notion supported by the finding that AMPK is central to nutrient stress responses in the
related parasite T. cruzi (84). This connection of positive and negative regulators of parasite
development is currently under further study, with an interest in separating individual
pathways and establishing interacting partners. Figure 1.13 is a cartoon rendition of the
proposed model that activation of TbAMPKα1 plays in LS to SS differentiation (79). The
presence of 5’-AMP analogs stimulates activation of TbAMPKα1 while inhibiting
TbTOR4 signaling, which is a negative regulator of LS into SS development (85). This
cascade allows mitochondrial activation and drives parasites to SS differentiation. If
however, TbAMPKα1 is inhibited by TbGSK3 or Compound C, TbTOR4 remains active,
leaving the mitochondria silent and causing the parasites to retain their LS characteristics.
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Figure 1.13: Model of TbAMPKα1 regulation of parasite differentiation. TbAMPKα1
activation is essential to drive LS to SS parasite differentiation. Inhibition of TbAMPKα1,
through TbGSK3 or Compound C, keeps parasites in the LS life cycle stage. Activation of
TbAMPKα1, through 5’-AMP analogs, drives parasites to differentiate into the SS life
cycle stage. Reprinted with permission from Elsevier Science & Technology Journals, Cell
reports. Copyright: Elsevier Science & Technology Journals, (79).
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Contributions
I contributed to this work parasite preparation from mouse blood. This included
preparation of the buffy coats and purification of parasites through DEAE chromatography.
I performed flow cytometry experiments on parasite surface molecule staining. This
required fixing cells at determined time points and performing EP staining for analysis by
flow cytometry. EP staining was performed on parasites from glucose/citrate/cold-shock
experiments (Figure 2.3). Additionally, I prepared cells for epifluorescence microscopy.
This involved fixing cells at determined time points for later immunofluorescence assays
for EP or PAD1 proteins for visualization by microscopy (Figure 2.2). I prepared LS
parasites in low glucose media supplemented with amino acids (Figure 2.4). I isolated
RNA samples from parasites for use in qRT-PCR and RNA-seq analysis. I also performed
qRT-PCR analysis of LS and PF parasites of several genes (THT1, THT2A, EP1, PAD,
TbHK1, COX VI, RBP5, RBP6, GAPDH) (Figure 2.7). Additionally, I assisted with cell
culture throughout all experiments.
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Abstract
The African trypanosome has evolved mechanisms to adapt to changes in nutrient
availability that occur during its lifecycle. During transition from mammalian blood to
insect vector gut, parasites experience a rapid reduction in environmental glucose. Here
we describe how pleomorphic parasites respond to glucose depletion with a focus on
parasite changes in energy metabolism and growth. Long slender bloodstream form
parasites were rapidly killed as glucose concentrations fell, while short stumpy
bloodstream form parasites persisted to differentiate into the insect stage procyclic form
parasite. The rate of differentiation was slower than that triggered by other cues but
reached physiological rates when combined with cold shock. Both differentiation and
growth of resulting procyclic form parasites were inhibited by glucose and nonmetabolizable glucose analogs and these parasites were found to have upregulated amino
acid metabolic pathway component gene expression. In summary, glucose transitions from
the primary metabolite of the blood stage infection to a negative regulator of cell
development and growth in the insect vector, suggesting that the hexose is not only a key
metabolic agent but is also an important signaling molecule.
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Introduction
Organisms that occupy multiple biological niches must adapt to different
environments. Such is the case for the vector-borne African trypanosome, Trypanosoma
brucei, a kinetoplastid parasite that is the causative agent of African sleeping sickness. This
parasite, which is transmitted by tsetse flies, undergoes a series of developmental steps that
yield lifecycle stages which are uniquely adapted for life in the distinct hosts. These
adaptations include alterations to metabolic pathways that parallel differences in substrate
availability and expression of distinct surface molecules that are required for successful
colonization of the new environment.
In T. brucei development, differentiation events occur in both the mammalian host
and insect vector. As their density increases in the vertebrate bloodstream, long slender
(LS) blood form parasites perceive a quorum-dependent parasite-derived signal that
triggers differentiation into short stumpy (SS) blood form parasites, a non-dividing form
arrested in G0 of the cell cycle (1). When these SS parasites, which are pre-adapted for
life in the tsetse fly vector (2), are engulfed by a tsetse fly during a blood meal, they quickly
differentiate into dividing procyclic form (PF) parasites that are competent for completion
of the lifecycle in the fly.
Development is carefully coordinated with environmental setting, ensuring that the
appropriate lifecycle stage is initiated in the correct host and tissue. The ability to perceive
and respond to the environment requires detection of cues that trigger signaling pathways
to modulate gene expression. SS trypanosomes are exposed to an array of potential signals
including fluctuating temperatures, exposure to digestive processes in the fly gut, and
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interaction with other trypanosomes. Additionally, there are an assortment of small
molecules generated while the blood meal vehicle in which the SS parasites reside is
digested by the fly.
In resolving these sensing pathways, potential cues associated with development
have been tested. Exposure of SS parasites to a cold shock, specifically a change in
environmental temperature of more than 15oC, has been shown to trigger a nearly
immediate and reversible expression of the procyclic form (PF) surface molecule EP
procyclin (3). However, these cells failed to grow. As cell growth is a critical feature of
the transition from SS to PF, this observation suggested that that cold shock alone was
insufficient for complete initiation of the developmental program. Notably, cold shock
also triggered the expression of a family of carboxylate transporter proteins called “proteins
associated with differentiation (PAD)” that have been implicated in the differentiation
response triggered by a distinct cue, citrate and cis-aconitate (CCA). Without exposure to
cold shock, a high concentration of CCA (6 mM) is required to initiate differentiation.
However, exposure of SS parasites to cold shock, which results in increased surface
expression of PAD2, triggers EP procyclin expression at extremely low levels of cisaconitate (0.6-6 µM) (3,4). The tsetse fly midgut contains similar levels of citrate (15.9
µM) and this carboxylic acid has been found to mirror the impact of CCA in SS to PF
development, an observation that defines CCA as a potentially physiologically relevant cue
(3,5).
Additional cues may be associated with cold shock and citrate that enhance
differentiation from SS to PF parasites. These include exposure to mild acid or protease
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treatment (5-9). Treatment of SS parasites with either of these cues rapidly initiated EP
procyclin expression (~2 hours), but the response mechanisms were different. Mild acid
treatment, much like exposure to high levels of CCA, led to phosphorylation of TbPIP39,
a phosphatase component of the CCA differentiation cascade (10). This phosphorylation
event indicates activation of this differentiation pathway, which was not observed after
protease treatment. This suggested the response was due to a distinct signaling pathway
(9).
One aspect of differentiation is the adaptation to nutrients available in a particular
host. In mammalian blood, LS parasites are exposed to ~5 mM glucose and the hexose
serves as a critical carbon source for this form of the parasite. When bloodstream form
parasites are taken up by a feeding tsetse fly they experience a rapid drop in glucose
concentration, with the sugar depleted from the blood meal in ~15 minutes (11). In this
environment, SS parasites persist and differentiate into PF parasites. Reflecting the
reduced glucose levels in the environment, PF parasites complete the activation of
metabolic pathways that were initiated in the SS lifecycle stage required for metabolism of
amino acids like proline and threonine (12-14).
Glucose is a critical carbon source for African trypanosomes but its role in
development is unresolved. Manipulation of glucose levels in vitro has been shown to alter
developmental patterns and gene expression, suggesting a role for the sensing of the sugar
in parasite development. Cultured monomorphic bloodstream form (BF) parasites that do
not differentiate into SS could be prompted to differentiate into PF parasites by removal of
glucose and addition of glycerol to the growth medium (15). The low survival and
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differentiation rates, along with the phenomena being noted in a developmentally defective
strain, however, call into question the biological relevance of glucose as a single cue to
initiate this process. Additional evidence that glucose sensing may play a potential role in
development includes the observation that partial inhibition of glycolysis in monomorphic
BF with phloretin, a plant-derived dihydrochalcone, or 2-deoxy-glucose (2-DOG),
triggered genome-wide transcriptome changes that resembled expression patterns found in
SS to PF parasite differentiation. These transcriptome changes included the upregulation
of EP procyclin and many genes involved in energy metabolism (16,17). Lastly, PF
parasites were found to alter surface molecule expression in a glucose-dependent manner
(18,19) in a process that is regulated by mitochondrial enzymes (19). These studies suggest
that while glucose manipulation is not sufficient for initiation of a rapid differentiation
program in BF parasites, it may play a role in development across several lifecycle stages.
Here, we present evidence that culturing SS parasite in medium with minimal
glucose (~5 µM) triggers differentiation to PF parasites.

The rate of this glucose-

responsive differentiation as measured by EP procyclin expression and initiation of growth
was slower than rates observed with other known cues of differentiation. However, the
rate was enhanced to physiologically relevant levels when cells were also exposed to a
brief cold shock, which is a known potentiator of other differentiation cues. The resulting
PF parasites upregulated genes involved in amino acid metabolism to a greater extent than
those differentiated through CCA treatment, indicating a potential role for glucose in
nutrient adaptation.
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Results
Bloodstream form parasite rapidly deplete glucose from the environment
Responses to new environments are particularly important to parasitic microbes
that inhabit different hosts during their lifecycles. As African trypanosomes transition from
the glucose-rich blood of the mammalian host to the tsetse fly gut, they undergo a marked
change in environment.

One major change is the rapid (~15 min) depletion of

environmental glucose, the primary carbon source used to generate ATP during
bloodstream infection (11). This reduction in available glucose is at least in part due to the
metabolic activity of the parasites in the blood meal. Both pleomorphic LS and SS parasites
isolated from infected rodents rapidly consume glucose in vitro with 0.5 mM glucose being
nearly depleted from culture medium after a single day by both lifecycle stages (Fig 2.1A).
After one day, glucose levels were reduced to 37 ± 0.70 and 62 ± 0.60 µM for LS and SS,
respectively and the hexose concentration continued to fall on day two, reaching 1.7 ± 0.70
and 15 ± 0.90 µM. The precipitous decline in glucose availability had an impact on LS
parasite viability even though the potential carbon sources proline and threonine were
included in the medium. While more than 80% of the LS parasites were dead after two
days of culture under the very low glucose conditions, SS parasites were less sensitive with
>80% of the population viable after the same period (Fig 2.1B).
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Fig 2.1: Slender form (LS) and short stumpy form (SS) T. brucei rapidly deplete
glucose. Parasites isolated from rodent buffy coats by chromatography were washed
extensively in PBS and then resuspended (4 x 105/cells/mL for LS and 5 x 105 cells/mL
for SS) in RPMIθ supplemented with proline and threonine and different concentrations
of glucose.
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Fig 2.1: Slender form (LS) and short stumpy form (SS) T. brucei rapidly deplete
glucose. LS parasites (left column) were isolated after four days of infection and made
up nearly 100% of the parasite population as determined by microscopy, while the SS
samples (right columns) contained a mixture of SS (~90%) and LS (~10%) parasites as
scored by cytometry of PAD1-labeled parasites (not shown). (A) Glucose
concentrations in the medium were measured through time as described in the Materials
and Methods and standard deviation from experiments performed in triplicate indicated.
(B) Parasite viability was scored by propidium iodide staining.

Impact of glucose depletion on the differentiation and proliferation of pleomorphic
SS and LS and monomorphic BF parasites
Monomorphic BF parasites cultured in very low glucose medium supplemented
with glycerol undergo an inefficient differentiation to PF parasites (15). This process is
likely to be a response of monomorphic BF parasites to metabolic stress instead of an
orchestrated program in response to a developmental cue.

To determine if glucose

depletion had a similar impact on cell development in different mammalian lifecycle
stages, pleomorphic LS and SS form parasites were incubated in SDM79θ, a very low
glucose (~5 µM) PF culture medium that contains amino acids but that lacks glycerol.
Culture of SS parasites in SDM79θ under conditions that would normally support PF in
vitro growth (27oC, 5% CO2) led to detectable parasite outgrowth by day 3 (Fig 2.2A, open

57

circles). This rate of outgrowth was considerably slower than that generated by known
differentiation cues, which we have termed glucose-responsive slow differentiation (GRS
differentiation). SS parasites maintained in SDM79θ supplemented with 5 mM glucose
(filled circles) did not appreciably grow. While the highly motile and proliferative LS
pleomorphic parasites are superficially most similar to the BF monomorphic cells, the LS
parasites were different in that they did not tolerate culture in glucose depleted conditions
even when glycerol was added to the medium (S1 Fig A).
SS forms in the mammalian bloodstream are arrested in the cell cycle and do not
divide, suggesting that the cell proliferation observed after incubation in SDM79θ was a
consequence of these SS differentiating to PF. To confirm this, parasites were probed with
antiserum specific to the PF marker protein, EP procyclin, and analyzed by
immunofluorescence (IF) (Fig 2.2B). IF analysis of growing cells revealed that the
parasites were morphologically similar to PF cells, expressing a surface coat of EP
procyclin not observed in SS or in SS cultured in the presence of glucose (Fig 2.2B).
As an additional marker for development, parasites were probed with antiserum
specific for PAD1, a marker for SS parasites, and the highest signal was observed on the
surfaces of SS parasites freshly isolated from rodent blood, as has been described (Fig
2.2C) (4). Growing parasites generated by culture without glucose led to reduced PAD1
labeling, while the majority of those cultured in the presence of glucose for the same period
died. However, the few that persisted frequently harbored multiple nuclei, accumulated
PAD1 signal in the flagellum, and became elongated (Fig 2.2C). The inability of these
cells to progress further along the lifecycle suggests that glucose is a negative regulator of
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cellular development in the SS parasite. The outgrowth of the normally quiescent SS
parasites together with EP procyclin expression and reduction of PAD1 labeling was only
observed in the absence of glucose. The majority of the cells remained viable throughout
the treatment and the resulting parasites proliferated rapidly as long as they were
maintained in very low glucose medium. Together, the expression of PF parasite markers
and resumption of growth was indicative of differentiation to the insect form lifecycle stage
(S1 Fig B).
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Fig 2.2: T. brucei SS growth and surface molecule expression are influenced by
environmental glucose availability. (A) LS and SS parasites isolated from rodents
were washed extensively and resuspended in very low glucose PF medium, SDM79θ (glc, ~5 µM), supplemented with (5 mM) or without additional glucose at 27oC and
growth monitored. Growth curves are representative of at least two assays. (B and C)
IF analysis of parasites after incubation for seven days with or without glucose. Fixed
parasites were visualized by epifluorescence microscopy using antiserum against EP
procyclin (B) or PAD1 (C). DAPI was added with anti-fade reagent to stain the nucleus
and kinetoplast DNA in all samples. Scale bar = 5 μm.

GRS differentiation rates reach physiologically relevant rates when combined with
cold shock
Triggers that initiate SS to PF lifecycle stage differentiation have been widely
studied (3-9). While differentiation of SS parasites as a result of glucose depletion alone
was delayed when compared to other described triggers, the parasite is likely exposed to
multiple environmental conditions in the tsetse fly that could influence this rate. To
investigate the effect of additional cues on GRS differentiation, rates of surface molecule
expression and growth were monitored (Fig 2.3). Exposure of SS parasites to cold shock
in combination with citrate levels found in the tsetse fly midgut (15.9 µM, (5)) triggered
EP procyclin expression after three hours and cell growth after four days (Fig 2.3B and
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C). The doubling time of these cells between days 4 and 7 was ~64.5 hours (Fig 2.3C,
asterisks). Similarly, the combination of cold shock and the near-absence of glucose
yielded EP procyclin expression after three hours and cell proliferation was noted within
one day. In addition to proliferation, these cells also grew more rapidly compared to those
where citrate was added, with a doubling time of ~21.5 hours (open triangles) between
days 4 and 7.
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Fig 2.3:

The near-absence of glucose is synergistic with cold treatment in

triggering differentiation from SS to PF. Flow cytometry of (A) control experiments
(secondary alone (2ndary); LS, SS, and PF stained with antiserum to EP procyclin) and
(B) SS parasites after culture at 37oC or exposure to 20oC for 16 hours in HMI9 prior to
washing and resuspension in SDM79θ supplemented with 5 mM glucose (+glc) or with
physiological levels of citrate (15.9 µM). Cells were fixed at the indicated times, stained
with antiserum to EP procyclin, and scored by cytometry (5,000 cells/assay) (C) Growth
of parasites exposed to cold shock (20oC) or 37oC for 16 hours prior to initiation of this
experiment with combinations of other environmentally-relevant cues (at 27oC). Bars
indicate standard deviation in triplicate assays.

Mitochondrial metabolism is required during GRS differentiation
SS parasites can metabolize the abundant glucose in the blood of the mammalian
host much like LS parasites. However, SS parasites also express genes that prepare them
for life in the glucose-poor environment of the fly gut by upregulating genes required for
mitochondrial metabolic functions, including cytochrome C oxidase subunits (20) and
respiratory chain complex I genes (21). To test the potential contribution of mitochondrial
amino acid metabolism to differentiation, parasite growth was scored after manipulating
the available amino acids in the very low glucose (~ 5 µM) bloodstream form medium
RPMIθ. When SS parasites were cultured in medium that included proline and threonine
for two days prior to being transferred into glucose-free PF medium that had abundant
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amino acids (SDM79θ), most cells remained viable and differentiation occurred (Fig 2.4A,
open circles). Inclusion of threonine alone did not support parasite differentiation (open
triangles) while culture in proline alone (open squares) led to a slightly delayed entry into
growth when compared to medium with both proline and threonine. RPMIθ medium
lacking glucose and both amino acids did not support parasite viability (x symbol), with a
greater than 80% loss of SS parasite viability on day one (Fig 2.4B). Inhibition of oxidative
phosphorylation with oligomycin, an ATP synthase inhibitor, prevented differentiation and
was toxic to SS parasites cultured in very low glucose (Fig 2.4C, open squares and Fig
2.4D). These observations indicated that amino acid metabolism is likely important for
satisfying the metabolic needs of the trypanosomes in a minimal glucose environment
during GRS differentiation. The ability to adapt to the new carbon source in the absence
of glucose is limited to SS parasites, as LS forms are not viable under the same conditions.
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GRS differentiation is not enhanced by glycolysis inhibitors
In Saccharomyces cerevisiae, nutrient adaptation responses to glucose availability
are mediated through non-metabolic pathways that transduce extracellular or intracellular
glucose levels into recognizable signals (22). However, the importance of glucose to BF
parasite metabolism raises the possibility that culture in very low concentrations of the
carbon source could initiate a stress response related to either insufficient ATP production
by glycolysis or a failure to synthesize required glycolytic intermediates.
To elucidate the role of glycolysis on the GRS differentiation response in T. brucei,
parasites were cultured with a variety of sugars at different concentrations and their impact
on differentiation was scored. First, conditions were tested to determine if they met the
metabolic needs of the glycolysis-dependent LS parasites. As anticipated, 2-DOG, which
is phosphorylated by hexokinase and can then inhibit downstream glycolysis, was toxic to
LS parasites.

While 2-DOG metabolism may cause a disruption in cellular ATP

homeostasis (as ATP is consumed during phosphorylation of 2-DOG), 6-deoxy-glucose
(6-DOG), an analog of glucose that cannot be phosphorylated by hexokinase, and the fivecarbon sugar xylose did not support LS viability (S2 Fig A).
SS parasite outgrowth paralleled the depletion of glucose from the medium,
although the minimum concentration of glucose required to trigger this response is unclear.
When SS parasites were seeded into RPMIθ supplemented with increasing concentrations
of glucose (0, 5, and 50 µM), outgrowth was noted at about the same time regardless of the
concentration of glucose (S2 Fig B). Confounding the interpretation of this experiment,
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however, SS parasites rapidly metabolize glucose to low levels in culture (Fig 2.1), making
the assessment of the critical glucose concentration needed to initiate outgrowth difficult.
Non-metabolizable glucose analogs were considered next, in part because SS
parasites were anticipated to be less sensitive than LS to these compounds given their
ability to persist in the near-absence of glucose (Fig 2.1). Incubation with 2-DOG, much
like glucose, prevented SS GRS differentiation (Fig 2.5A), but this compound was acutely
toxic to the SS parasites with >70% lethality after two days of exposure (Fig 2.5B). The
compound 6-DOG is not a substrate for cellular hexokinases and thus cannot be
phosphorylated to enter glycolysis. Similar to 2-DOG and glucose, culturing SS parasites
with 5 mM 6-DOG prevented differentiation (Fig 2.5A). While incubation in 50 µM 6DOG prevented outgrowth, 5 µM compound had no impact on cells (Fig 2.5C). High
concentrations of both glucose and 6-DOG were gradually toxic to SS parasites, with nearcomplete loss of viability after four days in 5 mM of either compound (Fig 2.5D). Lastly,
xylose had no inhibitory impact on SS parasite GRS differentiation (Fig 2.5A) and, like
culturing in very low glucose, was minimally toxic to the SS parasites (Fig 2.5B).
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Pre-adaption of SS cells at the transcriptome level
SS parasites occupy two extremely different niches (the glucose-rich mammalian
blood and the glucose-poor fly midgut) and they express metabolic characters that would
allow survival in both hosts (2,23,24). SS parasites isolated from mammalian blood have
undergone a dramatic change in gene expression as they developed from LS forms (S1
Table). These SS parasites, and those generated in vitro from cultured LS pleomorphic
cells through a density-dependent mechanism (25), share similar profiles of statistically
significant differentially downregulated genes in a comparison of of Log2FC with an FDR
adjusted p <0.05 in at least one of the two studies (S3 Fig A, S2 Table). The trends for
upregulated differentially expressed genes were different but the total number of total
upregulated genes in the transition from LS to SS was also smaller.
SS cells were more resistant to culture in very low glucose media, a characteristic
of the tsetse fly midgut environment (Fig 2.1B). To explore the role that glucose depletion
has on gene expression, the transcriptomes of LS parasites, SS parasites cultured in high
glucose media, SS parasites cultured in very low glucose media, and PF parasites
differentiated from very low glucose media were used to generate a principle response
curve (PRC) (26) (S3 FigB). Overall, differentiation from LS to PF parasites yielded
changes in expression of many life-stage specific genes (S1 Table). During the transition
from LS to SS in the presence of glucose, there was a dramatic change in expression
profiles. However, the removal of glucose in the SS life cycle stage only led to a minor
alteration in gene expression (S3 Fig B) with a total of 14 upregulated and 21
downregulated genes detected when SS parasites cultured in very low glucose were
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compared to those maintained in high glucose through differential gene expression analysis
(S3 Table). Interestingly, one of the upregulated genes, DRBD5 (Tb927.6.3480), is
required to suppress ESAG9 expression (27,28). ESAG9 is a known stumpy-elevated
transcript, so its suppression is anticipated to occur as part of the developmental program
to the PF lifecycle stage. Three of the significantly regulated transcripts were also found
to be among the top genes associated with progression from LS to PF (Table 2.1).
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Table 2.1: The fold-change and adjusted p-values from the SS (+glc +AA) vs. SS (-glc
+AA) DGE comparison.
Top genes changing towards progression
Gene ID

Gene
product1

LogFC (LS
vs PF)2

Adj. pValue3

LogFC (SS+glc
vs SS-glc)4

Adj. pValue3

Tb927.6.510

GPEET

6.22

0.00E+00

0.94

4.70E-14

Tb927.10.15410
Tb927.10.10260
Tb927.11.6280

gMDH
EP1
PPDK

5.23
6.41
4.25

0.00E+00
8.53E-318
0.00E+00

0.57
0.86
0.3

3.00E-27
1.20E-47
1.30E-06

Tb927.10.2560

mMDH

3.51

0.00E+00

0.3

1.70E-07

Tb927.6.520
Tb927.7.5940

EP3-2
PAD2

5.76
2.14

0.00E+00
9.7596E-103

0.46
1.2

1.40E-19
1.50E-76

Tb927.3.4500
Tb927.7.210
Tb927.9.5900

FHc
PRODH
GDH

3.70
2.65
2.86

2.89E-310
5.36E-316
5.3834E-138

0.28
0.57
1.2

2.80E-05
9.70E-24
1.30E-82

Gene ID
Tb11.1690
Tb927.10.5620
Tb927.3.3270
Tb927.10.14140
Tb927.10.8230
Tb927.10.2890
Tb927.1.3830
Tb927.1.700
Tb927.10.3990
Tb927.10.6880

1

Top genes changing against progression
Gene
LogFC (LS
Adj. pLogFC (SS+glc
product1
vs PF)2
Value3
vs SS-glc)4
VSG
-22.12
0.00E+00
0.01
ALD
-1.51
1.69E-184
-0.41
PFK
-2.09
6.80E-129
-0.18
PYK1
PDI2
ENO
PGI
PGKC
DHH1
GAP

-2.76
-2.00
0.06
-1.49
-3.21
-0.55
-0.65

0.00E+00
2.3277E-174
3.42E-01
8.29E-93
6.71E-310
8.16E-08
1.01E-25

-0.5
-1.1
-0.24
-0.29
-0.43
-0.33
-0.75

Adj. pValue3
9.20E-01
3.40E-17
2.10E-02
3.40E-18
2.20E-97
2.10E-05
2.50E-06
2.50E-08
3.60E-07
6.50E-47

GPEET, GPEET procyclin; gMDH, glycosomal malate dehydrogenase; EP1, EP1

procyclin; PPDK, pyruvate phosphate dikinase; mMDH, mitochondrial malate
dehydrogenase; EP3-2, EP3-2 procyclin; PAD2, protein associated with differentiation 2;
FHc, cytosolic fumarate hydratase; PRODH, proline dehydrogenase; GDH, glutamate
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dehydrogenase; VSG, variant surface glycoprotein; ALD, fructose-bisphosphate aldolase;
PFK, ATP-dependent 6-phosphofructokinase; PYK1, pyruvate kinase 1; PDI2, protein
disulfide isomerase 2; ENO, enolase; PGI, glucose-6-phosphate isomerase; PGKC,
phosphoglycerate kinase C; DHH1, DExD/H-box ATP-dependent RNA helicase.
2

LogFC (LS vs PF), the log2-fold change value of transcripts from LS incubated in in

glucose rich media compared to that from PF very low glucose media.
3

Adjusted p-value was calculated using the Benjamini-Hochberg method on p-values

generated by likelihood ratio.
4

LogFC (SS+glc vs SS-glc), the log2-fold change value of transcripts from SS incubated in

very low glucose media compared to that from SS in glucose rich media.

Pleomorphic PF cell growth is inhibited by glucose
Differentiation of PF parasites from SS parasites by either citrate treatment (6 mM)
or incubation in the near-absence of glucose yielded parasites with a growth deficiency
upon culture in glucose-rich medium (Fig 2.6A). These pleomorphic PF cells had average
doubling times (between days 4 and 7) that were 4.3-fold and 2.9-fold greater, respectively,
than the doubling time of parasites maintained in medium without glucose generated by
the same differentiation means (Fig 2.6A, compare filled symbols to open circles and
asterisks). The growth defect in the presence of glucose persisted for several weeks, with
cell division becoming nearly undetectable on day 12. However, cells continuously
cultured in glucose-replete medium eventually (3-4 weeks) resumed growth (S1 Fig B).
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The addition of 5 mM glucose to the environment slowed the growth of PF parasites
previously differentiated by glucose deprivation when compared to similar cells
maintained in very low glucose (Fig 2.6B, open squares compared to open circles, day 37). This growth retardation was relieved within one day of glucose removal from the
medium (open squares, day 8-14). While citrate-treated cells differentiated in the presence
of glucose within one day (filled triangles), these PF parasites had a reduced growth rate
when compared to cells differentiated by glucose depletion (open circles, day 3-7). This
growth retardation was partially relieved after ~3 days of culture in very low glucose (filled
triangles, day 8-14) but the ~30 hour doubling time still lagged behind the ~18 hours
doubling time of cells differentiated by glucose depletion (open squares, based on rates on
days 11-14). Glucose was not alone in its ability to temper pleomorphic PF growth, as 5
mM 6-DOG, but not lower concentrations (Fig 2.6D), was able to inhibit parasite growth
even though it is not a metabolizable sugar (Fig 2.6C, x symbol). Similarly, 2-DOG
inhibited growth of pleomorphic PF parasites differentiated in the absence of glucose (not
shown). Xylose had no impact on PF cell growth (Fig 2.6C, open triangles).
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Fig 2.6: Pleomorphic PF cell growth is suppressed in the presence of glucose. (A)
Comparison of growth of PF parasites differentiated from SS parasites by treatment
with 6 mM citrate in the presence of glucose (5 mM) to those differentiated by glucose
depletion. (B) Growth suppression was reversible by removal of glucose. SS parasites
were cultured for two days in the presence of citrate (6 mM) or near-absence of glucose
and then cultures were resuspended in glucose-replete or deficient SDM79θ for five
days, prior to dilution in fresh medium on the eighth day of growth. (C) Growth of
pleomorphic PF cells (differentiated for 7 days from SS) in SDM79θ with assorted
sugars (6-DOG, 6-deoxy-glucose; xyl, xylose) or (D) in different concentrations of 6DOG. Panel A and B are representative of at least duplicate assays, while in panel C
the bars indicate standard deviation in triplicate assays.
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PF parasites differentiated in glucose depleted medium upregulate amino acids
metabolism
Comparison of transcriptome profiles of LS parasites to PF parasites differentiated
by culture of SS parasites in very low glucose (5 μM) by differential gene expression
analyses revealed that a total of 1,310 transcripts were differentially-regulated in the PF
cells, with 694 upregulated and 616 downregulated genes (false discovery rate (FDR) <
0.05, |logFC| ≥ 1.0, and counts per million (CPM) > 10; S1 Table for a complete list and
verification of a subset by qRT-PCR). This result agrees with previous transcriptome
studies which found that a similar number of total genes were differentially expressed
between the LS and PF life stages (23,29).
To determine if the different cues used to trigger differentiation yielded distinct
transcript profiles, the data sets for PF parasites differentiated by culture in very low
glucose or by culture with CCA in the presence of glucose were compared to the
transcriptome of LS parasites (23,29). Transcripts encoding proteins known to be enriched
in BF parasites, like ESAG2, ESAG11, THT1-, and phosphoglycerate kinase C (PGKC)
were significantly downregulated in both PF transcriptomes, whereas those known to be
enriched in PF parasites, including EP1, EP2, EP3, GPEET, trypanosome hexose
transporter 2A (THT2A), purine nucleoside transporter NT10, and several proteins
involved in electron transport chain and mitochondrial translation were significantly
upregulated (Fig 2.7A).
While these life-stage-specific marker genes were similarly regulated, differences
in the regulation of genes involved in major metabolic pathways were observed. Genes
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required for glycolysis, the primary catabolic pathway used for ATP production in BF
parasites, were largely downregulated (60% of the known or predicted genes in the
pathway) in PF parasites differentiated by culture in glucose depleted medium, while PF
parasites differentiated by the presence of cis-aconitate had 20% of the known or predicted
genes in the pathway downregulated (Fig 2.7B, S4 Table). The percentage of upregulated
genes involved in gluconeogenesis was higher in PF parasites differentiated by glucose
depletion (50%) than those differentiated by cis-aconitate, where the expression of genes
in the pathway remained largely unchanged (Fig 2.7B, S4 Table). Similarly, the percentage
of upregulated genes known to be required for succinate and acetate/acetyl-CoA
metabolism were higher in PF parasites generated by glucose depletion (56% of known
genes involved) than in cis-aconitate differentiated PF parasites (11%).
A larger difference was noted for changes in expression of genes in pathways
associated with amino acid metabolism. While the cis-aconitate differentiated PF parasites
showed upregulation in several transcripts involved in proline catabolism and electron
transport chain (such as succinyl-CoA synthetase alpha subunit (Tb927.3.2230), succinate
dehydrogenase assembly factor 2 (SDHAF2, Tb927.6.2510), and the mitochondrial
precursor of Rieske iron-sulfur protein (RISP, Tb927.9.14160), to name a few, the majority
of transcripts in the pathways were unchanged (Fig 2.7B, S4 Table). By comparison,
expression of most of the known genes involved in proline, threonine, and electron
transporter chain (~78%, ~100%, and ~93%, respectively) were upregulated in PF parasites
generated by GRS differentiation.
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Fig 2.7: Evaluation of pleomorphic PF differentiated by different cues at the
transcriptome level. (A) A comparison of the relative transcript abundance of PF
parasites to LS parasites for a subsect of life stage-enriched genes. PF were generated
by differentiation of SS parasites using either glucose depleted medium (-glc) or cisaconitate treatment (+cis-aconitate). All transcripts included had >2-fold change and
adjusted p-values < 0.05 except for THT1- in PF (+cis-aconitate), which was
downregulated less than twofold with an adjusted p-value > 0.05. N/A, data not
available. ESAG2, expression site-associated gene 2; ESAG11, expression siteassociated gene 11; EP1, EP1 procyclin; EP2, EP2 procyclin; EP3-2, EP3-2 procyclin;
GPEET, GPEET procyclin; PSSA-2, procyclic form surface phosphoprotein;
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Fig 2.7: Evaluation of pleomorphic PF differentiated by different cues at the
transcriptome level. THT1-, glucose transporter 1B; THT2A, glucose transporter 2A;
NT10, purine nucleoside transporter 10; PGKB, phosphoglycerate kinase B; PGKC,
phosphoglycerate kinase C; RISP, rieske iron-sulfur protein; COXV, cytochrome
oxidase subunit V; COXVIII, cytochrome oxidase subunit VIII; COXIX, cytochrome
oxidase subunit IX; ATPF1G, ATP synthase F1 subunit gamma protein; PHB1,
prohibitin 1, PHB2, prohibitin 2 (B) The percentage of transcripts in major metabolic
pathways (as identified by GO term definition and confirmed in TrypanoCyc (60)) that
are regulated in PF differentiated by cis-aconitate or glucose depletion compared to LS.
For glycolysis and gluconeogenesis, only enzymes that participate in one of the
reactions were included. Upregulated transcripts are those that increased > 2-fold and
had adjusted p-values < 0.05 in PF compared to LS, while downregulated transcripts
were decreased > 2-fold with adjusted p-values < 0.05. Chi-squared goodness of fit
tests were performed for genes in each pathway to determine whether the proportions
of regulated genes between PF differentiated by cis-aconitate and glucose depletion
were different. ** indicates p-value < 0.01, suggesting transcripts involved in the
pathway are differentially regulated in PFs differentiated by the two cues.
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Discussion
Cellular mechanisms for adaptation to environmental nutrient availability are found
in organisms as divergent as microbes and humans. These mechanisms typically initiate
upregulation of alternative metabolic pathways, reduction of macromolecule synthesis in
response to limited nutrients, and enhancement of the expression of genes that may
improve organism dispersal to ultimately lead to colonization of new, nutrient-rich
environments. Additional responses include those that trigger development into quiescent
or environmental-resistant forms that can tolerate exposure to hostile environments.
The rapid depletion of glucose from a tsetse fly blood meal, as described by
Vickerman (11), suggests that glucose abundance could serve as a cue for developmental
programming. However, the rate of GRS differentiation is, by itself, likely too slow to be
biologically relevant. It is interesting, however, that combination with other treatments
known to influence differentiation (but that are by themselves insufficient to trigger
differentiation) potentiated the rate of differentiation to levels similar to those observed
with described cues. A temporary cold shock treatment (9) combined with culture in very
low glucose led to detectable EP procyclin protein expression after three hours and
outgrowth within one day. This was a notable reduction from the three-day period required
when parasites were grown in minimal glucose alone (Fig 2.3). Cold shock treatment also
upregulates the carboxylate transporter PAD2 and is therefore important for sensitizing SS
parasites to physiologically-relevant levels of CCA (3,4). Interestingly, glucose depletion
also upregulated PAD2 expression. Given that glucose is precipitously depleted from the
blood meal (11), the upregulation of PAD2 in response to glucose depletion may serve as
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an additional or alternative means of increasing SS parasite sensitivity to CCA. It is also
interesting that many expression site associated genes (ESAGs) are significantly regulated
both during the transition from LS to PF and when glucose is removed from SS (S1, S3
Table). Expression changes of these genes, which are proximal to telomeres, suggests a
potential variation in active expression sites. Others have postulated that environmental
stimuli can influence gene expression and ultimately developmental fate by modification
of chromatin at the epigenetic level (30).
The differentiation of SS parasites in response to reduced glucose availability
required inclusion of amino acids in the medium at the initiation of, and throughout,
differentiation and yielded PF parasites with transcriptome-wide alteration of the
expression of major metabolic pathway genes, a pattern not found in PF parasites
differentiated through cis-aconitate treatment.

This difference suggests that glucose

availability may influence activation of metabolic pathways required for different
developmental stages. To assess if the gene expression pattern was uniquely associated
with glucose depletion, the transcriptome changes in response to glucose depletion were
compared to transcriptional data generated from analysis of nine other transcriptomes (S4
Table) (17,25,29,31-36).

The analyses include transcriptomes from pleomorphic

EATRO1125 LS and PF and pleomorphic TREU927 LS and PF generated from mousederived SS parasites with 6 mM of cis-aconitate, monomorphic Lister 427 BF and labadapted PF parasites, and monomorphic BF (Lister 427) parasites with RBP10 knocked
down.

These datasets provide insight at a genome-wide scale of the regulation of

transcripts during transition of trypanosomes from blood to insect stages. Because these
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were generated using different sample preparation methods, library construction
approaches, and bioinformatic methodologies, comparing the transcriptomes is challenging
and may potentially reduce the value of the data found in samples scored by more sensitive
approaches. Therefore, for this comparison, genes with a fold-change ≥ 2 and a p-value
<0.05 in a given study were considered as significantly regulated and the regulation (noted
as up- or downregulated) were then compared to those identified in this work. Five of the
transcriptomes with accessible statistical analysis were chosen as representatives and
differences and similarities to the transcriptome generated in this study were compared (S4
Fig). The cells used in the five treatments were maintained in media that contained at least
5 mM glucose (17,23,31,33,36).
While PF cells generated in these studies generally downregulated glycolytic genes
and upregulated amino acid metabolism genes, the proportion of the genes differentially
regulated in these categories was significantly different from the regulation generated by
glucose depletion (S4 Fig). Interestingly, the upregulation of the two hexokinase genes
was only observed when PF were maintained in media with very low glucose levels or
when the cells were supplemented with glycerol (S4 Table, Qiu, Queiroz, and
Naguleswaran columns). While the trend was not statistically significant, the overall
regulation of the glycolytic and amino acid metabolic pathways in these three PF lines was
highly similar. This similarity may not be a coincidence but may reflect the influence of
glucose and glycerol on a regulatory pathway. Consistent with this, inclusion of glucose
or glycerol in growth medium have been shown to have the opposite impact on GPEET
transcript levels, a marker of early PF parasites (19).
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In T. brucei, the transcriptional regulation largely occurs at the post-transcriptional
level, a process that frequently involves the action of RNA binding proteins (37). One such
RNA binding protein, RBP10, has been shown to play a major role during the transition of
parasites from blood to insect stages (17,38).

As an RNA binding protein that is

exclusively expressed in BF parasites, RBP10 influences gene expression at both transcript
and protein levels. Knocking down RBP10 in BF parasites has been found to trigger a
series of developmental changes that eventually give rise to PF parasites (38). Consistent
with a role in regulating development, RBP10 transcript levels were found to be
downregulated in most of the PF transcriptomes compared here, including the one derived
from glucose depletion in this study (S4 Table). Comparison of the genes that were
statistically significantly differentially expressed in the work presented here and in the
Mugo and Clayton study (38) revealed that transcriptional changes during transition from
the LS to PF tended to be similar in direction (either up or downregulated) but were of
greater magnitude than those found when RBP10 was silenced in BF parasites (S3 Fig C,D,
S1 Data). This suggests potential differences in the differentiation induced by the two
approaches (S3 Fig C) and may explain why the dramatic alteration of transcript abundance
for genes involved in energy metabolism observed in our study was also not observed in
RBP10 knockdown BF cells (S4 Fig; S4 Table). A similar trend was visible when
comparing the transition from LS to SS to BF with RBP10 RNAi but the number of
statistically significantly differentially expressed genes shared between these comparisons
were significantly lower (S3 Fig D, S1 File).

83

GRS differentiation includes a nutrient adaptation mechanism that responds to
glucose, either as a result of the perception of a signal through glucose metabolism or by
signaling through a glucose-specific receptor-mediated pathway. The observation that
GRS differentiation in SS parasites was inhibited by low concentrations of 6-DOG, a
glucose analog that is not a substrate for glycolysis, suggests that T. brucei perceives the
presence of the hexose through a glycolysis-independent pathway. In other eukaryotes,
glucose receptor-mediated signaling is known to influence cellular responses to
extracellular glucose (39,40). The identity of potential glucose receptors that would
participate in this sort of response in T. brucei is unknown, but it is possible that one or
more of the trypanosome hexose transporter family members, or one of the hexokinases,
could serve this role, given that they have similar KM values (52 μM for the trypanosome
hexose transporter 2 and 90 μM for the trypanosome hexokinase 1) to the concentration of
glucose required to inhibit GRS differentiation (50 μM) (41,42).

However, the

involvement of glucose metabolism in cellular development and nutrient adaptation cannot
be completely ruled out. Treatment of monomorphic BF with phloretin, a glucose uptake
inhibitor, has been shown to trigger a differentiation-like transcriptome change in the
parasites (16).
The pleomorphic PF parasites generated by the GRS differentiation offer additional
evidence for two pathways to sense glucose. First, 6-DOG inhibited growth of these PF
cells, suggesting metabolism was connected to the observed growth repression. However,
the onset of growth inhibition by addition of glucose to the medium was more rapid than
that observed using 6-DOG (Fig 2.6C), possibly because it activated both the glycolysis-
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dependent and the glucose receptor-mediated pathways simultaneously, while 6-DOG
could only initiate the receptor-mediated pathway. Alternatively, glucose uptake may have
been more efficient which could impact the activity of an intracellular glucose binding
protein-based response.
While LS parasites are dependent on host glucose for ATP production, PF parasites
have a more dynamic metabolism and are capable of utilizing either amino acids or sugars
as carbon sources. Laboratory-adapted PF parasites grown in glucose-rich culture media
preferentially metabolize glucose with coincident downregulation of proline consumption
(43,44). PF parasites generated by culture of SS forms in reduced glucose media responded
to the sugar differently, by displaying growth inhibition (Fig 2.6). This was similar to
glucose-induced growth inhibition noted in PF parasites isolated from tsetse fly midguts
(45), which presumably occurred because these parasites had been adapted to the amino
acid-rich fly gut environment (46). Additionally, the negative impact of glucose on parasite
growth may explain why trypanosome infections are more readily established in bloodstarved tsetse flies than in fed insects (47,48).
In conclusion, the glucose signaling pathway in the African trypanosome may not
be directly connected to glycolysis, but the pathway does play an important role in the
metabolic adaptation of the parasite (Fig 2.7, S3 Fig A, S4 Table), which may in turn
influence other aspects of developmental differentiation through known pathways.
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Materials & Methods
Ethics Statement
All procedures were carried out in accordance with the PHS Policy on the Care and
Use of Laboratory Animals and in accord with the CU PHS Assurance Number A3737-01
under the approval of the Clemson University Institutional Animal Care and Use
Committee (IACUC). Clemson University animal research and teaching facilities and
programs are registered by USDA, Animal Care (AC) [Registration Number 56-R-0002]
and animal research programs and facilities have full accreditation from the Association
for Assessment and Accreditation of Laboratory Animal Care, International (AAALAC).
Euthanasia by heavy anesthetization followed by bilateral pneumothorax was used based
on recommendations from the AVAM Guidelines for the Euthanasia of Animals.

Trypanosomes and cell culture conditions
Trypanosoma brucei brucei 427 BF parasites, a representative monomorphic strain,
were cultured as described in HMI-9 medium (49). LS and SS T. brucei EATRO1125 were
isolated from infected Swiss Webster mice 3-4 or 6-7 days after infection, respectively, by
preparation of buffy coats and purification through DEAE chromatography. Cells were
maintained in HMI-9 medium (with LS density kept under 5 × 105 cells/mL) for one day

before use.

To assess trypanosome responses to environmental manipulations, a BF medium
with very low glucose, RPMIθ, was made by modifying HMI-9 (49) with additional
features adapted from (50) including replacement of IMDM with glucose-free RPMI that
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has been buffered with HEPES to pH 7.4, elimination of SerumPlus and use of dialyzed
FBS (10% f.c.). A PF medium with very low glucose, SDM79θ, was generated by
eliminating glucose from SDM79 (51) using dialyzed FBS (10% f.c.) in lieu of standard
serum. Both media have a final glucose concentration of ~5 µM. To score the impact of
culturing under extremely low glucose conditions, parasites were washed three times in
warmed PBS to eliminate residual glucose before resuspension at ~5 × 105 cells/mL in

prewarmed (at 27°C) SDM79θ with or without additional carbon sources or glucose
analogs added. Cultures were incubated at 27°C in 5% CO2 with their medium changed
every two days. Cell numbers were scored daily during the first week and every-other-day

in the second week and cell viability determined by propidium iodide (PI) staining (0.5
μg/ml final concentration) followed by flow cytometry on an Accuri BD flow cytometer
(BD Biosciences, San Jose, CA).

Glucose measurements
To assay the glucose concentration in the parasite growth medium, an Amplex™
Red Glucose/Glucose Oxidase Assay Kit (Invitrogen, Carlsbad CA) was used. All time
points were tested in triplicate, with parasites removed by centrifugation (16,000 x g, 2
min) and supernatant tested according to the protocol provided by the manufacturer.

RNA analysis
To assess the consequence of glucose availability on steady-state transcript
abundance, RNAseq was performed on LS cells isolated from rodents and cultured in
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HMI9 for one day, SS cells incubated for one day in RPMIθ with or without added glucose
(5 mM) supplemented with or without proline and threonine, and PF cells differentiated
from SS in very low glucose. Three biological replicates of each treatment were conducted
and RNA was isolated using an Aurum Total RNA Mini Kit (Bio-Rad). Libraries were
constructed using the TruSeq Stranded mRNA Library Prep Kit (Illumina, San Diego, CA
USA). The total RNA fraction was enriched for mRNA using poly(A) capture and libraries
were constructed using the TruSeq Stranded mRNA kit. Quality metrics were analyzed for
all samples using FastQC (http://www.bioinformatics.babraham.ac.uk/projects/fastqc).
Trimming of low quality bases and adapter sequences was performed using trimmomatic
(52). Trimmed reads were aligned using gsnap to the TriTrypDB-28_TbruceiTREU927
genome, minus the 11 bin scaffold/chromosome. The maximum number of mismatches
allowed was determined by the formula ((readlength+index_interval-1)/kmer - 2)), where
readlength = 150 and index_interval=3. Subread’s featureCounts counted by transcript
including only uniquely mapped, concordantly aligned, reversely stranded paired-end
reads (53). Raw read counts (S5 Table) were then used as input to edgeR for differential
gene expression (DGE) analysis using generalized linear models (GLM) (54,55). The
BioProject accession number is PRJNA438967, which contains all raw data in this study.
Genes with low coverage across all samples were filtered out, and library sizes were
normalized using the trimmed mean of M-values method. Sample comparisons were set
up as likelihood ratio tests, and genes having a FDR of < 0.05, |logFC| ≥ 1.0, and CPM >10
were considered to have significant expression abundance changes.
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To verify the quality of RNAseq, qRT-PCR was performed using a Verso 1-step
RT-qPCR Kit (ThermoFisher) in a CFX96 Touch™ Real-Time PCR Detection System
(Bio-Rad) for selected transcripts. Ct values of transcripts were used to solve relative
expression by the comparative Ct (2-ΔΔCT) method using the expression of the telomerase
reverse transcriptase (TERT) gene or 60S ribosomal protein L10a (RPL10A) as reference
as described (16,56,57). Primers for transcripts were designed through Genscript Realtime PCR (TaqMan) Primer Design (https://www.genscript.com/tools/real-time-pcrtagman-primer-design-tool) and confirmed by blasting against the Trypanosoma brucei
brucei TREU927 transcriptome database on TritrypDB (http://tritrypdb.org/tritrypdb/). A
list of primers used in qRT-PCR can be found in S5 Table.

Flow cytometry and epifluorescence microscopy
For analysis of surface molecule expression of parasites by flow cytometry,
antibody staining was performed using protocols modified from (58). Briefly, 0.5-2 × 106

cells were washed in PBS and fixed in 4% formaldehyde/0.05% glutaraldehyde for 1 hour
at 4°C. Cells then incubated in blocking solution (2% BSA in PBS) for 1 hour before
application of FITC-conjugated EP procyclin antibody (monoclonal antibody TBRP1/247,
Cedarlane Laboratories, 1:1000) or PAD1 antibody (a generous gift of Dr. Keith Matthews,
University of Edinburgh, 1:1000). Cells were washed three times in PBS before addition
of Alexa Fluor 488-conjugated goat anti-mouse (1:1000) or goat anti-rabbit secondary
antibody (ThermoFisher Scientific, 1:1000) prior to analysis by flow cytometry.
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Immunofluorescence assays were performed using a protocol modified from (59).
Parasites (1 × 106 cells) were harvested (800 x g, 8 min), washed with PBS, and then fixed
in 4% formaldehyde in PBS for 30 minutes at 4°C. Cells were washed with PBS, allowed
to settle on poly-lysine coated slides, and permeabilized with 0.1% Triton X-100 in PBS
for 30 min. After being washed in PBS, cells were incubated in blocking solution (10%
normal goat serum and 0.1% Triton X-100 in PBS) for 1 hour at room temperature,
followed by addition of the FITC conjugated EP procyclin antibody diluted at 1:100 or
PAD1 antibody diluted at 1:100 in blocking solution. Primary antibodies were detected
with Alexa Fluor 488-conjugated antiserum diluted at 1:1000. Vectashield mounting
medium with DAPI was applied for the detection of nucleus and kinetoplast DNA. Cells
were visualized on a Zeiss Axiovert 200M using Axiovision software version 4.6.3 for
image analysis.

Metadata analyses
SRA data was downloaded from BioProjects PRJEB13058 (38) and PRJEB19907
(25). Due to differences in library preparation and sequencing, the Qiu et al. dataset had to
exclude all R2 reads, Qiu et al. and Naguleswaran et al. datasets had to be truncated to 50
bps, and Mugo and Clayton and Naguleswaran et al. datasets had to be downsampled to
10 million reads per sample. Seqtk was used for truncating and downsampling. The
downsampling was done post-trimming, with trimmomatic, for low quality bases and
adapter sequences. The resulting fastq files were aligned by gsnap to the TriTrypDB28_TbruceiTREU927 genome, minus the 11 bin chromosome. Subread’s featureCounts
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was used to identify reads uniquely aligned to known genes. All reads were considered
unstranded for alignment and feature calling. A table of all samples’ counts was used as
input to edgeR for differential gene expression analyses. Following the pipeline used in
this study, DGE analysis was used to compare total RNA fractions of BF to BF RBP10
RNAi from Mugo and Clayton, LS to SS from Naguleswaran et al., and, LS to SS and LS
to PF from Qui et al. The normalization, modeling and comparison for the dataset from
Mugo and Clayton. had to be analyzed separately post-filtering due to considerable
technical variations in the gene counts. DGE tables are presented in supplementary table 5
(S5 Table) and supplementary data 1 (S1 Data). Comparison by comparison log2FC
scatterplot are presented in S3 Fig C and D.
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Abstract
Trypanosoma brucei is a unicellular protozoan parasite that causes disease in
humans and cattle. Parasites are transferred from one host to another through the tsetse fly
vector. The trypanosome can rapidly alter their metabolism and modify surface proteins to
tolerate each environment. One stark difference between the fly digestive tract and
mammalian blood is the abundance of glucose. Nutrient sensing and signaling plays a key
role in development through the T. brucei life cycle. Here, we explore the role of the
catalytic α subunit of AMPK, a eukaryotic master regulator of metabolism, in procyclic
form T. brucei. The PF parasite expressed two AMPKα1 species and both were detected
using antibodies generated against phosphorylated human AMPKα. We found that the
larger species of phosphorylated AMPKα1 (p-AMPKα1), coined p-AMPKα1+, was more
abundant in the presence of glucose, and other metabolizable sugars. Subcellular location
of AMPKα1 was similar regardless of glucose abundance and the phosphorylated version
of AMPKα1was partially associated with glycosomes and mitochondria. The glucose
specific response of AMPKα1 in T. brucei may reflect a role of for the complex in
regulating metabolism through nutrient sensing during parasite differentiation.
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Introduction
Trypanosoma brucei is the eukaryotic protozoan parasite that causes the diseases
African sleeping sickness and nagana, in humans and cattle, respectively. T. brucei is a
unicellular parasite and has a strictly extracellular dixenous life cycle. In mammals, the
parasite lives in the blood, lymph, fat, skin, and other tissues (1) and is transmitted between
hosts by the tsetse fly (Glossina spp). When the parasites are ingested by the tsetse fly
during a blood-meal, they are introduced into the midgut of the fly and continue through
life-cycle stages required for success in the vector.
The mammalian bloodstream and the tsetse fly midgut differ dramatically in
nutrient availability. When the parasites reside in the mammalian bloodstream glucose is
abundant (~ 5 mM) (2) and serves as the lone carbon source for the bloodstream form
parasite (BSF), which relies solely on glycolysis for generation of ATP. The long slender
bloodstream form parasite (LS) grows in the blood. In a population density-dependent
fashion, LS parasites differentiate to the quiescent short stumpy forms (SS) (3,4). Feeding
tsetse flies take up parasites in their bloodmeal. These parasites experience a rapid change
in environment when they are delivered to the fly midgut, as they are abruptly transferred
from the glucose-rich blood environment to the amino acid-rich, glucose limited fly
digestive tract. This change, and other cues, trigger SS parasites to differentiate into PF.
The dramatic change in nutrient availability forces the parasites to reprogram their
metabolism from glycolysis to oxidative phosphorylation to generate ATP (5).
Many of the environmental cues that T. brucei perceives function through welldefined signaling pathways (6). These signaling pathways are triggered by nutrient
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availability, quorum sensing, and host extracellular signals (5, 6 , 7). Several of the triggers
ultimately converge on the AMPK pathway. AMPK is a master regulator of energy
metabolism that senses and responds to AMP:ATP ratios within the cell (8, 9). AMPK is a
canonical regulator of eukaryotic cell metabolism (10) that consists of a heterotrimeric
protein complex made up of a catalytic α domain, a β scaffold domain, and a γ regulatory
domain. Activation of AMPK occurs through phosphorylation of the catalytic domain
when the AMP:ATP ratio is high, which indicates an energy deficit (11), may result from
carbon source deprivation or cellular stress (12). T. brucei have two isoforms of the
catalytic subunit, α1 and α2, which have 50% identity (Chapter One, Table 1.1).
T. brucei undergoes rapid glucose starvation when parasites are transferred from
the mammalian bloodstream to the tsetse fly midgut, with glucose depleted from the blood
meal to undetectable levels within 15 minutes (13). This change in environment coincides
with perception of development cues that trigger progression of SS to PF stages. Previous
studies of T. brucei differentiation have described roles for several signaling components
in development, including the eukaryotic metabolic regulator, the target of rapamycin
(TOR) kinase, which plays a role in parasite metabolic reprogramming (14). TbTOR4 has
been shown to play a role in differentiation of long slender parasites into short stumpy
parasites in a cAMP-dependent mechanism (14, 15). Additionally, signal transduction
studies in T. brucei have highlighted the importance of cAMP signaling through cAMP
effector kinases and phosphatases in the parasite (16). cAMP signaling in T. brucei is
distinct from that found in mammalian cells, as the parasites lack G-protein-coupled
receptors, and instead, likely use receptor-type adenylate cyclases in the pathway (reviewed
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in (17)). Interestingly, the trypanosome flagellum has been found to be an important site
of cAMP signaling and environmental sensing. This organelle interfaces with the host
environment and is ideally positioned to house these key sensing pathways (18, 21).
More recently, studies have implicated a role for AMPK in T. brucei differentiation
(3, 20, 21). Changes in PF surface molecule expression, a part of the normal developmental
progression of the parasite, are modulated by glucose abundance, an observation that
manipulation of AMPK subunit abundance by RNAi can phenocopy (22). This suggests a
connection between the protein complex and nutrient perception. Additionally, TbAMPKα
is a positive regulator of parasite development from LS to SS, tying together nutrient
abundance and metabolism in differentiation (23). It remains unclear how AMPK receives
and transduces the ATP deficit signal within the parasite. We hypothesize that TbAMPKα
phosphorylation occurs in response to glucose abundance and is key to successful parasite
differentiation. In this study we explore the role of AMPKα in the PF response to glucose
abundance to better understand activation of AMPK and to elucidate potential signaling
partners.
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Materials and Methods
Cells Lines and Culturing
WMI 471 Antat 1.1 pleomorphic procyclic form Trypanosoma brucei brucei were cultured
in SDM-79 medium (Gibco, Thermofisher Scientific, Waltham, MA) supplemented with
10% FBS or SDM-79θ medium (Gibco, Thermofisher Scientific, Waltham, MA)
supplemented with 10% dialyzed FBS. SDM79 has a final glucose concentration of 9 mM,
while SDM79θ has a final concentration of ~4µM. For some experiments, pleomorphic
procyclic form cells harboring pXS2:aldoPTSeYFP were used, as they constituently
express a glycosomally targeted eYFP. Cell cultures were maintained in the log phase of
growth at 27°C in 5% CO2 .
Western Blots
Whole cell lysate or subcellular fractions were resuspended in 2X cracking buffer (40 mM
tris pH 6.8, 0.4% (w/v) SDS, 4% β-mercaptoethanol (v/v), 0.4% (v/v) bromophenol blue,
5% (w/v) glycerol) and electrophoresed on 8% SDS-PAGE until the dye front ran off the
gel. Samples were transferred at 16V for 40 min in transfer buffer (0.58% (w/v) tris base,
2.9% (w/v) glycine, 5% (v/v) methanol, 0.0375% (v/v) 10% SDS) and transferred to 0.45
µm nitrocellulose membranes (Amershan Protran GE Healthcare Life Science).
Membranes were blocked in 3% milk (w/v) (Nestle Carnation instant dry non-fat milk) in
1X TNT (10 mM Tris pH 8, 150 mM NaCl, 0.0005% (v/v) Tween-20) for 1 h shaking at
RT. Membranes were incubated with primary antibodies for 1 h shaking at RT. Rabbit antialdolase, rabbit anti-Hsp70 (StressMarq Bioscience), mouse anti-PPDK (generous gift
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from Dr. Frederic Bringaud), and rabbit anti-TbHK1 (hexokinase 1) were diluted in 3%
(w/v) milk in 1X TNT at dilutions of 1:100,000 1:5,000, 1:10,000, and 1:100,000
respectively. Rabbit anti-AMPKα and rabbit anti-phosphoAMPKα antibodies (Cell
Signaling Technologies 2532 and 2535, respectively) were diluted in 5% BSA (w/v)
(Fisher Bioreagents) in 1X TNT at dilutions of 1:1,000 and 1:10,000 respectively.
Membranes were washed 3 times for 5 min in 1X TNT. Secondary Horseradish Peroxidase
(HRP) antibodies (Rockland) to each respective primary host were diluted 1:10,000 in 3%
(w/v) milk in 1X TNT and incubated for 1 h shaking at RT. Membranes were developed
using Enhanced Chemiluminescence (ECL) substrates (SuperSignal west pico Plus
Chemiluminescent substrate ThermoScientific) and imaged using x-ray film (MTC bio).
In order to reprobe transfers, membranes were washed in 1X TNT after developing and
stripped using 0.1M glycine pH 2.5 for 30 min, washed 3 times for 5 min in 1X TNT, and
blocked in 3%(w/v) milk in 1X TNT for 1 h shaking at RT. Densitometry analysis, through
relative darkness, was scored using Image J version 64-bit.

Immunofluorescence Assays
Cells (2x106 ) were harvested at 800 x g for 15 min, washed once in 1X phosphate-buffered

saline (PBS) and resuspend to a density of 2x107 cells/mL in 1X PBS and fixed in 4%

paraformaldehyde in 1X PBS. Fixed cells settled for 30 min on a glass slide, inside a pappen wax box, and washed 3 times in wash solution (0.1% normal goat serum (NGS) in 1X
PBS). Cells were then permeabilized (0.5% (v/v) triton X-100 in 1X PBS) for 20 min then
washed. Cells were blocked (10% NGS, 0.1% triton X-100 in 1X PBS) for 1 h at RT then
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washed. Primary antibodies, rabbit-AMPKα or rabbit-phosphoAMPKα, were diluted 1:250
in block solution and incubated for 1 h on the slide at RT, then washed 3 times. Secondary
antibody, either anti-rabbit Alexa fluor 488 or anti-rabbit Alexa fluor 568 (Abcam), were
diluted 1:1,000 in block solution and incubated for 1 h on the slide at RT and kept dark.
After secondary was washed three times cells were mounted in Prolonged Glass Antifade
Mountant with NucBlue (Invitrogen) and a coverslip was added. The slide was allowed to
cure for 48 h at RT in the dark. Slides were then sealed and imaged on a Leica DiM8
(Leica Microsystems Inc, Buffalo Grove, IL). Cells (2x106 ) stained with MitoTracker

RedTM cmxROS (Invitrogen) were harvested at 800 x g for 15 min, washed once in 1X

PBS and resuspend in 10 µM MitoTracker RedTM cmxROS (Invitrogen) in 1X PBS and
incubated at 27°C and 5% CO2 in the dark for 30 min, then proceeded to fix for
immunofluorescence assays.

Differential Centrifugation
Cells (5x108 ) were harvested at 800 x g for 15 min and washed once in 1X PBS. Cells
were resuspended in a 50% (w/v) slurry of silica carbide in 1X STE (250 mM sucrose, 25
mM Tris-HCl pH 7.4, 1 mM EDTA) supplemented with 1 mM phenylmethylsulphonyl
fluoride (PMSF) in dimethyl sulfoxide (DMSO). Mechanical lysis was performed by pestle
for 5 min in a microcentrifuge tube. The silica carbide slurry was removed by
centrifugation at 100 x g for 30 seconds and cell lysate supernatant was transferred to a
fresh microcentrifuge tube. Samples were then centrifuged (2,000 x g, 10 min, 4°C) to
yield the nuclear pellet. The post-nuclear lysate was transferred to a fresh tube and the
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mitochondria-rich fraction was pelleted (5,000 x g, 10 min, 4°C). Subsequent
centrifugation steps (all 10 min at 4°C) at 17,000 x g and 100,000 x g yielded glycosomes
and endosome-rich fractions, respectively. Post-endosomal supernatant was acetone
precipitated and cytosolic proteins were pelleted (17,000 x g, 10 min, 4°C). Sub-cellular
faction pellets were resuspended in 20 µL 2X cracking buffer and proteins resolved by
10% SDS-PAGE.

Sucrose Density Gradient Fractionation
Otiprep (Accurate Chemical) was diluted in dilution buffer (0.25 M sucrose, 1 mM EDTA,
5 mM MOPS, 0.1% v/v ethanol, pH 7.2) to a final concentration of 50% (v/v) Iodixanol.
Fifty percent Iodixanol working solution was diluted in homogenization buffer (0.25 M
sucrose, 6 mM EDTA, 30 mM MOPS, 0.6% v/v ethanol) to final concentrations of 20%,
24%, 30%, 34%, 40%, and 50% Iodixanol. Fractions were added to 14 x 95 mm thin wall
polypropylene centrifuge tubes. A cushion of 300 µL of 50% Iodixanol was loaded at the
base of the gradient. Discontinuous fractions of 2.4 mL of decreasing Iodixanol
concentrations were gently added on top of previous layer to total 13 mL gradient from
50% Iodixanol at the bottom to 20% Iodixanol at the top. Sucrose gradients were prepared
the day before sample isolation and allowed to equilibrate at 4°C overnight. Cells (1x109 )

were harvested at 800 x g for 15 min and washed once in 1X PBS. Cells were resuspended
in a slurry silica carbide in 1X STE + 1mM PMSF. Mechanical lysis was performed by
pestle for 5 min in a microcentrifuge tube. The silica carbide slurry was removed by
pelleting at 100 x g, 30 seconds and cell lysate supernatant was transferred to the top of a
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pre-prepared sucrose gradient. Loaded gradients were placed into a swinging bucket SW40Ti rotor and centrifuged at 30,000 x g, 17 h, 4°C. Fractions were carefully collected in
500 µL aliquots beginning at the top of the gradient. Each fractions protein abundance was
assessed through BCA assay (Thermofisher). Protein from every fraction (10 µg) was
acetone precipitated at 4°C and resuspended in 20 µL 2X cracking buffer and proteins
resolved by 8% SDS-PAGE for western blot analysis.
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Results
AMPK is a master regulator of metabolic responses to energy homeostasis in
eukaryotes. Previous studies have shown that AMPK plays a role in differentiation of T.
brucei with AMPKα playing a role in the quorum sensing pathway as a potential signal
transducer, acting upstream of TbTOR4 (24,25). AMPKα1, the catalytic subunit, has been
shown to act as a central signaling molecule in the differentiation of T.brucei (3,20). Here,
we explored the phosphorylation of AMPKα in PF parasites cultured in the presence or
absence of glucose, as well as subcellular location of AMPKα. Interestingly, we have found
that further phosphorylation (with putative activation) of AMPKa1 does not coincide with
changes in glucose abundance. Rather, the phosphorylated (putatively active) protein is
further post-translationally modified in response to glucose.
In other systems, AMPK is phosphorylated in response to high AMP levels by an
autocatalytic phosphorylation of threonine 172 on the AMPKα subunit (11,26). To
determine if glucose availability impacted phosphorylation of the active loop threonine in
the trypanosome enzyme (TbAMPKα1 and TbAMPKα2 at Thr165 and Thr167
respectively), we performed western blotting using an antibody specific for phosphorylated
human AMPKα (p-AMPKα) that has been used by others to score activation of AMPK in
trypanosomes (20). This phosphorylated threonine in the active loop of the catalytic
domain and serves as a marker for activation of AMPKα.

112

A

B

C

Figure 3.1: The phosphorylated AMPKα1 subunit is modified in the presence of
glucose. (A) Western blot of PF whole cell lysate from cells cultured in the presence or
absence of glucose using an antibody that detects phosphorylated AMPKα. (B) Both
AMPK α1 and α2 are delectable with the anti-phosphoAMPK antibody in trypanosomes.
(C) Schematic showing two species of p-AMPKα1, with the larger species observed in the
presence of glucose (p-AMPKα1+) and the smaller species prevalent in the absence of
glucose (p-AMPKα1).

113

There are two α subunits (α1 and α2) in trypanosomes, which share 50% identity,
Figure 3.1A shows that phosphorylated AMPKα1 (p-AMPKα1) was detectable in
parasites independent of the presence of glucose in culture medium. Similarly, AMPKα2
was phosphorylated. in cells cultured in the presence and absence of glucose (Figure 3.1B,
lower band, approx. 70 kDa). However, we detected two subspecies of p-AMPKα1, each
around 80 kDa. The modest difference in mobility of the two p-AMPKα1 on the western
blot suggested the presence of an additional post-translational modification (PTM) on pAMPKα1, which we hypothesize is an additional phosphorylation (Figure 3.1C). Notably,
culture of parasites in the presence of glucose resulted in the predominance of the larger
species of p-AMPKα1, which we coined p-AMPKα1+, hypothesized to be
hyperphosphorylated AMPKα1. PF cultured in the absence of glucose yielded
predominately smaller of p-AMPKα1 species (Figure 3.1A).
To determine if there was a difference in the abundance of p-AMPKα protein levels
between PF in the presence and absence of glucose we performed densitometry analysis
on western blots probed with the anti-phosphoAMPKα antibody. Comparing activated pAMPKα signal to a loading control of tubulin (which does not change in response to
glucose) we calculated the relative protein abundance of both p-AMPKα1 and p-AMPKα2
(Figure 3.2A). Both isoforms were significantly more abundant in PF parasites cultured in
the absence of glucose (Figure 3.2B). There was no change in overall AMPKα protein
level in response to glucose (Figure 3.2C).
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A

B

Relative p-AMPKα subunit abundance

C

Figure 3.2: p-AMPKα is more abudant in the absence of glucose. (A) Western blot on
PF whole cell lysate of cells cultured in the presence or absence of glucose. TUB is tubulin
loading control (B) Densitometry analysis of three biological replicates p-AMPKα1 and pAMPKα2 subunits in the presence and absence of glucose. * = p < 0.05 ** = p < 0.01 (C)
representative western blot of AMPKα abundance of cells cultured in the presence or
absence of glucose polyclonal anti-AMPKα antibody TUB is tubulin loading control
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Figure 3.3: p-AMPKα1 is modified within 5 min of glucose treatment. Western blot of
PF parasites continuously cultured in the presence (top panel), or absence (bottom panel),
were treated in either the presence or absence of glucose and incubated for 5, or 30, or 60
min. p-AMPKα2 did not respond to glucose abundance.

PF parasites continuously cultured in either the presence (Figure 3.3, top panel), or
absence (Figure 3.3, bottom panel), of glucose were centrifuged, washed to remove
residual culture media, and resuspended in media supplemented with or without glucose
for various amounts of time. The p-AMPKα1+ levels of PF cultured in presence of glucose
rapidly falls when glucose is removed from the environment (Figure 3.3, top panel). When
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PF cultured in the absence of glucose were resuspended in glucose-bearing media, pAMPKα1 was rapidly (~ 5 minutes) modified to p-AMPKα1+ (Figure 3.3, bottom panel).
To decipher if this response was occurring through either glucose sensing or
glucose metabolism, we exposed PF cultured in the absence of glucose to various sugars.
p-AMPKα1 was modified into p-AMPKα1+ in the presence of glucose, mannose, and
fructose, but not galactose (Figure 3.4A). It has been established that trypanosomes
transport glucose, mannose, and fructose into the cell, while galactose is not a substrate for
the cellular transport machinery (27), suggesting that a hexose must enter the cell before
triggering a response. To better understand the role of glucose metabolism in p-AMPKα1
response we treated PF parasites cultured in the absence of glucose with either glucose or
the glucose analogs 2-deoxyglucose (2DOG), or 6-dexoyglucose (6DOG) (Figure 3.4B).
These analogs have different fates in the cell. Both are transported into the parasite, but
only 2DOG is phosphorylated by the trypanosome hexokinase (TbHK). In the presence of
glucose p-AMPKα1 is modified into p-AMPKα1+. Interestingly, this modification also
occurs when the cells were cultured with the glucose analog 2DOG. Both glucose and
2DOG are substrates for TbHK. Notably, 6DOG, which is not a substrate of TbHK, was
unable to trigger the change in AMPKα1. Figure 3.4C is a schematic of TbHK activity in
the presence of glucose, 2DOG, or 6DOG.
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A

B

C

Figure 3.4: p-AMPKα1 is only modified in the presence of metabolizable sugars. (A)
Western blot of PF treated with 10mM various sugars, pyruvate phosphate dikinase
(PPDK) as a loading control (B) western blot of PF treated with 500µM glucose analogs,
tubulin (TUB) as a loading control (C) Schematic showing glucose analog metabolism
through TbHK
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To further explore the role of glucose metabolism in the modification of AMPKα1,
we assessed the impact of a known AMPK activator, the AMP analog AICAR, on the
modification of AMPKα1. Western blot analysis of PF parasites treated with 2DOG or
AICAR resulted in the modification of p-AMPKα1 into p-AMPKα1+ (Figure 3.5A).
However, treatment with 6DOG did not elicit the p-AMPKα1+ modification. This suggests
that p-AMPKα1+ is generated as a consequence of AMPK activity and that hexokinase
substrates can trigger the same response through glucose metabolism.

Figure 3.5: p-AMPKα1 is modified by known AMPK activators. (A) western blot of
PF cultured in the absence of glucose treated with the 500µM glucose analogs, 6DOG or
2DOG, or 10mM AICAR.
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Knowing that glucose abundance influences p-AMPKα1 modification, we explored
subcellular distribution of AMPKα and p-AMPKα in PF parasites in response to glucose
availability. We performed differential centrifugation of lysates of PF parasites cultured in
the presence or absence of glucose, collecting nuclear, mitochondrial, glycosomal,
endosomal, and cytosolic enriched fractions (Figure 3.6A). By western blotting we did not
observe a difference in the distribution of p-AMPKα1 in response to the presence or
absence of glucose (Figure 3.6B). We observed that p-AMPKα1 primarily fractionated in
the nuclear fraction, suggesting association with the nucleus or fragments of the plasma
membrane. We also performed crude fractionations on PF parasites after they were
introduced in the opposing glucose abundance of culture media. We saw no difference in
fraction location of p- AMPKα1 in response to glucose abundance.
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A

B

Figure 3.6: p-AMPKα does not change subcellular location in the presence of glucose.
(A) cartoon method of differential centrifugation created with BioRender. N-nuclear
enriched, M- mitochondria enriched, G- glycosome enriched, E- endosome enriched, Ccytosol enriched. (B) western blot of differential centrifugation fractions of PF in the
presence or absence of glucose. PPDK as a glycosomal marker, HK as a glycosomal and
cytosolic marker.
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To further resolve the subcellular location of p-AMPKα we performed sucrose
density gradient fractionation of PF parasites cultured in the presence and absence of
glucose (Figure 3.7A). We observed a similar fractionation pattern of p-AMPKα using
lysates of parasites cultured in the presence (Figure 3.7B) or the absence (Figure 3.7C) of
glucose. Here, Hsp70 serves as a mitochondrial marker and aldolase as a glycosomal
marker. We also observed a similar fractionation of AMPKα with the AMPKα antibody,
regardless of glucose abundance. Observing p-AMPKα only in the ‘top’ of our gradient,
we decided to precipitate protein from the first nine fractions, representing the top third of
the sucrose gradient and the smallest molecules, to increase our subcellular resolution.
Upon western blotting analysis of the top third of the gradients we did not observe a change
in the density association of p-AMPKα in response to glucose abundance (Figure 3.8A &
B).
Densitometry analysis of protein abundance in individual fractions showed partial
overlap in distribution of AMPKα and mitochondria and glycosomes in the presence and
absence of glucose (Figure 3.8 C & D). Glycosomes and mitochondria markers had similar
fractionation patterns regardless of glucose abundance. It should be noted that this analysis
cannot provide information about protein abundance, but rather presence of proteins in a
fraction (above the limit of detection). The fractionation of AMPKα was similar in PF
lysates in the presence and absence of glucose (Figure 3.8E), as was also true of pAMPKα1 (Figure 3.8F). Similarity, when we compared the density fractionation of
AMPKα to p-AMPKα in the first nine fractions, we observed a similar distribution of the
two proteins, in both the presence and absence of glucose (Figure 3.9 A & B). Rather than
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glucose abundance altering the protein abundance of AMPKα, it seemed that
phosphorylation of AMPKα1 plays a larger role in subcellular location, in a glucose
independent mechanism.
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B

C

Figure 3.7: p-AMPKα has similar subcellular distribution regardless of glucose
abundance.
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Figure 3.7: p-AMPKα has similar subcellular distribution regardless of glucose
abundance (A) Cartoon rendition of sucrose gradient fractionation method created with
BioRender (B) western blot analysis of every third fraction collected from PF parasites
cultured in the presence of glucose. Hsp70 as a mitochondrial marker and aldolase as a
glycosomal marker (C) western blot analysis of every third fraction collected from PF
parasites cultured in the absence of glucose. Hsp70 as a mitochondrial marker and aldolase
as a glycosomal marker
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B

Figure 3.8: AMPKα has similar subcellular distribution to other organelle markers
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D
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F

Figure 3.8: AMPKα has similar subcellular distribution to other organelle markers.
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Figure 3.8: AMPKα has similar subcellular distribution to other organelle markers.
(A) western blot analysis of first nine fractions of sucrose gradient fractionation collected
from PF parasites cultured in the presence of glucose, Hsp70 as a mitochondrial marker
and aldolase as a glycosomal marker (B) western blot analysis of first nine fractions of
sucrose gradient fractionation collected from PF parasites cultured in the absence of
glucose, Hsp70 as a mitochondrial marker and aldolase as a glycosomal marker (C)
densitometry analysis of protein abundance of specific subcellular markers per first nine
fractions in the presence of glucose. Glyco- aldolase signal, mito- Hsp70 signal (D)
densitometry analysis of protein abundance of specific subcellular markers per first nine
fractions in the absence of glucose. Glyco- aldolase signal, mito- Hsp70 signal (E)
densitometry analysis of AMPKα in the first nine fractions the presence or absence of
glucose (F) densitometry analysis of p-AMPKα in the first nine fractions the presence or
absence of glucose
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A

B

Figure 3.9: p-AMPKα has a distinct subcellular distribution when compared to
AMPKα, regardless of glucose abundance. (A) densitometry analysis of AMPKα vs pAMPKα in the first nine fractions the presence of glucose (B) densitometry analysis of
AMPKα vs p-AMPKα in the first nine fractions the absence of glucose.

129

In addition to sucrose gradient fractionation, we performed immunofluorescence
assays on PF parasites cultured in the presence or absence of glucose. Here, we aimed to
complement our previous data showing partial organellar cofractionation of parasite lysate
through localization studies on PF parasites. We observed partial overlap in fluorescence,
visualized by yellow color, of the glycosomal marker, in red, with AMPKα, in green
(Figure 3.10A). We also observe partial overlap in fluorescence of the glycosomal marker
with p-AMPKα (Figure 3.10B). This corroborates our previous data of cofractionation of
p-AMPKα1 with glycosomes. Further, Clemmens et al previously demonstrated that
AMPKβ, in red, was partially associated with glycosomes, in green (Figure 3.10C) (22).
AMPK is widely distributed in the cell, with protein localization shown to overlap with
mitochondria, visualized by the yellow color (Figure 3.11A). This localization did not
change after activation of the enzyme (Figure 3.11B). This supports our previous sucrose
gradient fractionation data of partial association of AMPKα with mitochondria.
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Glycosome
Figure 3.10: AMPKα may be associated with glycosomes.
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Figure 3.10: AMPKα may be associated with glycosomes. (A) Immunofluorescence on
PF parasites expressing glycosomally directed fluorophore cultured in the presence of
glucose, top row, or absence of glucose, bottom row. Stained with native AMPKα, green.
Scale bar = 10µm (B) Immunofluorescence on PF parasites expressing glycosomally
directed fluorophore cultured in the presence of glucose, top row, or absence of glucose,
bottom row. Stained with p-AMPKα, green. Scale bar = 10µm (C) Immunofluorescence
on PF parasites expressing glycosomally directed fluorophore, green, stained with
AMPKβ, red. Scale bar = 5µm. Reprinted with permission from Elsevier Science &
Technology Journals, Experimental Parasitology. Copyright: Elsevier Science &
Technology Journals, 2009 (22).
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A

B

Figure

3.11:

AMPKα

is

partially

associated

with

mitochondria.

(A)

Immunofluorescence on PF parasites cultured in the presence of glucose, top row, or
absence of glucose, bottom row. Live PF parasites stained with 10µM MitoTracker Red,
then fixed and stained with AMPKα, green. Scale bar = 10µm (B) Immunofluorescence on
PF parasites cultured in the presence of glucose, top row, or absence of glucose, bottom
row. Live PF parasites stained with 10µM MitoTracker Red, then fixed and stained with
p-AMPKα, green. Scale bar = 10µm
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Discussion
In this study, we have found that phosphorylated AMPKα1 can be present in two
subspecies in a glucose dependent fashion, suggesting additional dynamic posttranslational modifications (PTM) of the catalytic domain. The additional modification of
p-AMPKα1, which we coined p-AMPKα1+, was repeatedly detected in parasites cultured
in the presence of glucose (Figure 3.1). Phosphorylated AMPKα (α1 & α2) were more
abundant in parasites cultured in the absence of glucose, (Figure 3.2). This was likely due
to an increase in AMPKα phosphorylation in the absence of glucose, rather than an increase
in total protein abundance.
The activation of AMPK may be related to its role in down-regulation of anabolism
and induction of catabolic programs similar to the function of the complex in other
eukaryotic systems. Introduction of environmental glucose led to rapid (within five
minutes) modification of p-AMPKα1 (Figure 3.3). We hypothesize that glucosedependent modification may be the activity of increased cellular AMP responsive
pathways. However, the T. brucei genome does not contain a predicted homolog of the
LKB1 gene, which is responsible for direct activation of AMPK in other eukaryotic
systems. This may be similar to the path triggered by canonical AMPK activators in other
systems that cause autophosphorylation of AMPKα1 in response to cAMP analogs (Figure
3.5).
Figure 3.12 shows our current working model for AMPKα modification in
relationship to glucose metabolism. In the presence of extracellular glucose (Figure
3.12A), glucose enters the parasite cytoplasm through a THT and is shuttled to the
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glycosome in a mechanism that is not fully understood. Once in the glycosome, glucose is
metabolized

into

glucose-6-phosphate

(G6P)

by

TbHK.

This

substrate-level

phosphorylation alters the ADP:ATP ratio inside the parasite. Also occurring in the
cytoplasm AMPKα is phosphorylated, activating the AMPK complex, as a result of natural
cellular processes that increase cytosolic AMP levels. We hypothesize that this activated
AMPK complex nears the glycosome, senses the energy imbalance caused by TbHK
metabolism and the AMPK complex becomes hyper-phosphorylated (p-AMPKα1+). This
modification of the AMPK complex may play a role in decreasing activity of the complex
through reversible PTMs rather than protein degradation. The hyper-phosphorylated
AMPK complex is also hypothesized to play a role in surface molecule composition by
favoring EP procyclins.
In the absence of extracellular glucose (Figure 3.12B) TbHK is not active. Here,
in the cytoplasm AMPKα is phosphorylated, activating the AMPK complex, as a result of
natural cellular processes that increase cytosolic AMP levels. The activated AMPK
complex is hypothesized to signal mitochondrial metabolism, increasing catabolic
activities. Surface molecule composition is altered, with GPEET procyclins being detected
on the PF parasite cell surface in the absence of glucose. This proposed model of AMPKα
PTM and AMPK signaling ties together glucose metabolism, mitochondrial metabolism,
and surface molecule composition.
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A

B

Figure 3.12: Working model of AMPKα modification in response to glucose
metabolism. (A) AMPK signaling in the presence of glucose. Created with BioRender.
(B) AMPK signaling in the absence of glucose. Created with BioRender.
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Having found partial overlap of AMPKα with both glycosomes and mitochondria,
in both our fractionation and immunofluorescence experiments, it is possible that AMPKα
may be reversibly associated with membranes. The N-terminus of the TbAMPKβ subunit
contains a putative myristoylation site that has been shown to direct cytoplasmic to
membrane translocation of the AMPK complex in other systems (28). We did not
investigate the β-subunit in this study. However, it would be interesting to see the β-subunit
is causing the change in AMPK subcellular localization in response to glucose depletion.
Parasite surface molecule expression is tightly associated with differentiation, as
particular life cycle stages require expression of surface proteins for success in their host
niche (29). LS and SS parasites express a dense surface coat of variant surface glycoprotein
(VSG) which enable antigenic variation and host immune evasion in mammals (30) while
PF parasites express procyclins on their surface, which are important for tissue tropism in
the fly. In Chapter Two we explored the role that glucose depletion plays in parasite
differentiation. In this chapter, I suggest a role of AMPKα signaling in a glucose
metabolism-dependent manner.
RNAi screens found AMPKα2 to play a role in differential gene expression of
parasite differentiation (25). RNAi knockdown of AMPKβ, the scaffold subunit of the
heterotrimeric complex, caused a change in parasite surface molecule composition, a result
that phenocopied how PF cells respond to glucose deprivation (Chapter 1, Figure 1.10)
(22). This suggests that AMPK signaling is potentially involved in regulation of surface
molecule expression in response to environmental cues.
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Two phosphatases, TbPTP1 and TbPIP39, have been found to play a role in T.
brucei differentiation from SS to PF (31). TbPTP1, a tyrosine phosphatase,
dephosphorylates TbPIP39, a serine/threonine phosphatase, a cascade that is necessary for
parasite development. Recent studies have tied phosphorylation of AMPKα with TbPIP39
expression (32) suggesting that AMPK is upstream of TbPTP1. Other phosphatases and
kinases have been shown to potentially play a role in T. brucei differentiation, including
TbTOR4, a known negative regulator of LS to SS development (23,33). AMPKα1 has been
found to be upstream of TOR4 in T. brucei, these pathways are inversely connected in other
eukaryotic systems (34). Taken together, these results suggest that TbAMPKα is playing a
role in nutrient sensing and signaling in PF parasites, and this signaling may be
communicating with other known pathways. Metabolism reprogramming and
environmental sensing are essential to the completion of the parasite life cycle, and
TbAMPKα phosphorylation, and hypothesized hyper-phosphorylation, appears to respond
to glucose metabolism in PF parasites.
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CHAPTER FOUR
CONCLUSIONS AND FUTURE DIRECTIONS
African trypanosomes are unicellular protozoan parasites with a dixenous life
cycle. As the parasites are transferred between mammalian hosts through the tsetse fly their
metabolic requirements drastically change. While parasites live extracellularly in the
mammalian bloodstream, they metabolize glucose to generate ATP. Conversely, the
procyclic form parasites, living in the tsetse fly, have limited access to glucose and rather
metabolize amino acids to generate ATP (1). The stark difference in nutrient availability is
one of many cues required to drive completion of their lifecycle (2). Here, we hypothesize
that glucose metabolism plays a role in parasite differentiation through a mechanism that
shares some similarities but has differences from other eukaryotes.
Yeast utilize Snf1, a heterotrimeric protein complex consisting of a catalytic α
subunit, β scaffold subunit, and regulatory γ subunit, and this serves as a master regulator
in nutrient abundance perception (3). Snf1 is activated by high AMP:ATP ratios, signifying
cellular starvation, and transduces signals to induce catabolic activities while suppressing
anabolic activities (4). Activation of Snf1 occurs through phosphorylation of Thr210 of the
catalytic α subunit (5), an event that can occur in response to glucose uptake and
metabolism in Saccharomyces cerevisiae (6).
Mammalian cells contain the protein complex AMPK, a homologue of Snf1, which
consists of the homologs of the three Snf1 subunits. Similarly, AMPK is activated through
high AMP:ATP ratios, sensing low intracellular energy and signaling catabolic pathways
(7). The catalytic α subunit can be activated by phosphorylation of Thr172, which may
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only occur after allosteric interaction of adenine nucleotides with the regulatory γ subunit
(8). The canonical activation of AMPK, phosphorylation of catalytic α subunit Thr172, has
been tied to the depletion of environmental glucose. Other studies have shown AMPK
acting as a sensor of glucose abundance, partially through association with subcellular
membranes (9). The scaffold β subunit can be myristoylated to alter the subcellular location
of the AMPK complex as part of a cellular nutrient response (10).
Trypanosoma brucei has a complex lifecycle. The proliferative mammalian
bloodstream long slender (LS) form transitions into the quiescent short stumpy (SS) form
in a density-dependent fashion (11). SS parasites are preadapted to life in the tsetse fly with
proteins associated with differentiation (PAD) surface proteins, upregulated mitochondrial
transcripts, and resistance to mild acid. Upon a tsetse fly bloodmeal LS and SS parasites
are ingested and LS parasites are degraded. SS parasites receive several environmental
cues, including depletion of glucose and introduction of citrate/cis-aconitate, and further
differentiation into procyclic (PCF) form parasites (12). The transition from SS to PCF is
controlled through a protein phosphatase cascade which has found to be associated with
glycosomes.

Glycosomes

are

parasite

specific

specialized

peroxisomes

that

compartmentalize most of glycolysis, along with components of other metabolic pathways
(13,14). Our lab previous showed that glucose abundance played a key role in SS to PCF
differentiation (15). Another eukaryotic master regulator, TbTOR4, was found to
negatively regulate parasite development from LS to SS (16). We hypothesized that AMPK
to be at the center of coordination of parasite differentiation, influencing metabolic changes
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in the mitochondria and glycosome (17). This work aims to tie together glucose abundance
and metabolism to AMPK signaling in T. brucei.
In Chapter two I found that TbAMPKα1 is modified in response to glucose in PCF
parasites. We observed a species of TbAMPKα1 with slightly larger mobility on SDSPAGE, coined TbAMPKα1+, in the presence of glucose and other metabolizable sugars.
This response occurred rapidly, and with a similar phenotype to known AMPK activators.
The modification of TbAMPKα1 did not alter subcellular location. The modification of
TbAMPKα1+ remains unresolved. We have made several attempts to epitope tag the
catalytic α subunit to aid in the precipitation of the protein for further analysis without
success. Additionally, immunoprecipitation (IP) using native AMPKα antibodies have also
been unsuccessful. IP purification (and resulting very low concentration of what is
anticipated to be a signaling molecule) followed by mass spectrometry analysis could be
key unlocking TbAMPK interacting partners and piecing together the signaling cascade
that controls parasite differentiation.
In Chapter three I contributed to work that described how the depletion of glucose
is crucial, but not the only trigger, for SS to PCF differentiation. Pleomorphic SS parasites
isolated from infected rodents were subject to several experimental conditions, along with
published differentiation cues that included cold shock and citrate/cis-aconitate treatment.
Successful differentiation to PCF parasites was scored through outgrowth of the
population, metabolic transcript profile, and surface protein coat. I performed the flow
cytometry experiments of monitoring expression of the PCF surface molecule EP procyclin
on SS parasites subjected to experimental cues (experimental and published). I also
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prepared RNA samples from various stage of parasites for RNAseq and qRT-PCR analysis.
These RNA studies revealed that depletion of glucose induced a transcript profile in PCF
more similar to that found in PCFs from infected flies and distinct from those from PCFs
derived from SS that had been subjected to other differentiation cues. This work established
the foundation of thinking that glucose sensing and metabolism may be playing separate
roles in parasite differentiation.
Taken together, glucose metabolism and perception have been found to be key
regulators of parasite developmental programs. In a step toward better understanding of the
glucose-responsive signaling mechanisms in the parasite we have found that glucose
availability impacts the master metabolic regulator AMPK. Glucose and glucose
metabolism play roles in the activation of TbAMPKα1 and parasite differentiation, but
connections between the two have not been resolved and will require future efforts to
identify interacting partners in order to fully elucidate the pathway.
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